SEC Filing | Saratoga Investment Corp

Large Accelerated Filer

Accelerated Filer

Non-Accelerated Filer

Smaller Reporting Company

View:

Download DOC

Download PDF

Download XLS

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 2014

¨	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-33376

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)


Maryland		20-8700615
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

535 Madison Avenue New York, New York		10022
(Address of principal executive office)		(Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 14, 2015 was 5,401,899.

TABLE OF CONTENTS


		Page
PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements		3

	Consolidated Statements of Assets and Liabilities as of November 30, 2014 (unaudited) and February 28, 2014		3

	Consolidated Statements of Operations for the three and nine months ended November 30, 2014 and November 30, 2013 (unaudited)		4

	Consolidated Schedules of Investments as of November 30, 2014 (unaudited) and February 28, 2014		5

	Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2014 and November 30, 2013 (unaudited)		11

	Consolidated Statements of Cash Flows for the nine months ended November 30, 2014 and November 30, 2013 (unaudited)		12

	Notes to Consolidated Financial Statements as of November 30, 2014 (unaudited)		13

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		33

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		52

Item 4.	Controls and Procedures		52

PART II	OTHER INFORMATION		52

Item 1.	Legal Proceedings		52

Item 1A.	Risk Factors		53

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		53

Item 3.	Defaults upon Senior Securities		53

Item 4.	Mine Safety Disclosures		53

Item 5.	Other Information		53

Item 6.	Exhibits		53

Signatures			54

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities


	As of
	November 30, 2014			February 28, 2014
	(unaudited)
ASSETS
Investments at fair value
Non-control/non-affiliate investments (amortized cost of $222,452,952 and $185,266,607, respectively)	$	221,740,190		$	186,275,106
Control investments (cost of $16,384,467 and $16,555,808, respectively)		19,433,253			19,569,596

Total investments at fair value (amortized cost of $238,837,419 and $201,822,415, respectively)		241,173,443			205,844,702
Cash and cash equivalents		809,245			3,293,898
Cash and cash equivalents, reserve accounts		10,738,075			3,293,113
Interest receivable, (net of reserve of $411,334 and $150,058, respectively)		3,170,976			2,571,853
Deferred debt financing costs, net		4,921,925			4,008,704
Management fee receivable		178,234			150,106
Other assets		8,583			14,461

Total assets	$	261,000,481		$	219,176,837

LIABILITIES
Revolving credit facility	$	4,900,000		$	—
SBA debentures payable		79,000,000			50,000,000
Notes payable		48,300,000			48,300,000
Dividend payable		320,189			—
Management and incentive fees payable		4,551,236			3,856,962
Accounts payable and accrued expenses		550,565			824,568
Interest and debt fees payable		725,301			873,135
Due to manager		337,433			398,154

Total liabilities	$	138,684,724		$	104,252,819

Commitments and contingencies (See Note 7)
NET ASSETS
Common stock, par value $.001, 100,000,000 common shares authorized, 5,379,616 and 5,379,616 common shares issued and outstanding, respectively	$	5,380		$	5,380
Capital in excess of par value		184,851,154			184,851,154
Distribution in excess of net investment income		(23,752,974	)		(29,627,578	)
Accumulated net realized loss from investments and derivatives		(41,123,827	)		(44,327,225	)
Net unrealized appreciation on investments and derivatives		2,336,024			4,022,287

Total net assets		122,315,757			114,924,018

Total liabilities and net assets	$	261,000,481		$	219,176,837

NET ASSET VALUE PER SHARE	$	22.74		$	21.36

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)


	For the three months ended November 30						For the nine months ended November 30
	2014			2013			2014			2013
INVESTMENT INCOME
Interest from investments
Non-control/Non-affiliate investments	$	5,038,877		$	4,279,445		$	14,794,342		$	11,534,271
Payment-in-kind interest income from Non-control/Non-affiliate investments		319,994			161,485			902,536			634,408
Control investments		694,641			556,291			1,996,010			2,791,830

Total interest income		6,053,512			4,997,221			17,692,888			14,960,509
Interest from cash and cash equivalents		1,024			1,316			2,738			7,181
Management fee income		383,012			421,198			1,150,505			1,400,039
Other income		867,409			381,480			1,078,239			838,956

Total investment income		7,304,957			5,801,215			19,924,370			17,206,685

EXPENSES
Interest and debt financing expenses		1,869,176			1,611,221			5,466,279			4,342,657
Base management fees		1,087,734			876,345			3,093,399			2,424,167
Professional fees		225,776			312,992			937,083			879,247
Administrator expenses		250,000			250,000			750,000			750,000
Incentive management fees		851,806			(561,539	)		2,022,423			219,813
Insurance		83,388			117,955			252,002			357,184
Directors fees and expenses		51,000			35,978			159,761			131,978
General & administrative		176,293			251,058			400,487			440,844
Other expense		—			9,172			—			21,207

Total expenses		4,595,173			2,903,182			13,081,434			9,567,097

NET INVESTMENT INCOME		2,709,784			2,898,033			6,842,936			7,639,588

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:
Net realized gain from investments		2,761,558			82,882			3,203,399			1,157,824
Net unrealized depreciation on investments		(2,005,072	)		(1,713,025	)		(1,686,263	)		(3,770,968	)

Net gain/(loss) on investments		756,486			(1,630,143	)		1,517,136			(2,613,144	)

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	3,466,270		$	1,267,890		$	8,360,072		$	5,026,444

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE	$	0.64		$	0.26		$	1.55		$	1.05
WEIGHTED AVERAGE COMMON STOCK OUTSTANDING—BASIC AND DILUTED		5,379,616			4,851,451			5,379,616			4,770,267

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2014

(unaudited)


Company	Industry	Investment Interest Rate / Maturity	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Non-control/Non-affiliated investments—181.3% (b)
National Truck Protection Co., Inc. (d), (g)	Automotive Aftermarket	Common Stock		1,116	$	1,000,000	$	1,631,710		1.3	%
National Truck Protection Co., Inc. (d)	Automotive Aftermarket	First Lien Term Loan 15.50% Cash, 9/13/2018	$	7,737,848		7,737,848		7,737,848		6.3	%
Take 5 Oil Change, L.L.C. (d), (g)	Automotive Aftermarket	Common Stock		7,128		480,536		1,347,406		1.2	%

		Total Automotive Aftermarket				9,218,384		10,716,964		8.8	%

Legacy Cabinets Holdings (d), (g)	Building Products	Common Stock Voting A-1		2,535		220,900		1,468,475		1.2	%
Legacy Cabinets Holdings (d), (g)	Building Products	Common Stock Voting B-1		1,600		139,425		926,848		0.8	%

		Total Building Products				360,325		2,395,323		2.0	%

BMC Software, Inc. (d)	Business Services	First Lien Term Loan 5.00% Cash, 9/10/2020	$	5,746,667		5,699,544		5,650,123		4.6	%
Dispensing Dynamics International (d)	Business Services	Senior Secured Note 12.50% Cash, 1/1/2018	$	7,000,000		6,903,658		7,490,000		6.1	%
Easy Ice, LLC (d)	Business Services	First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018	$	7,661,668		7,588,434		7,661,669		6.3	%
Emily Street Enterprises, L.L.C.	Business Services	Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017	$	5,807,354		5,711,778		5,807,354		4.7	%
Emily Street Enterprises, L.L.C. (g)	Business Services	Warrant Membership Interests		49,318		400,000		375,310		0.3	%
Help/Systems Holdings, Inc. (Help/Systems, LLC) (d)	Business Services	First Lien Term Loan 5.50% Cash, 6/28/2019	$	1,960,000		1,945,399		1,940,400		1.6	%
Help/Systems Holdings, Inc. (Help/Systems, LLC) (d)	Business Services	Second Lien Term Loan 9.50% Cash, 6/28/2020	$	2,000,000		1,974,499		1,990,000		1.6	%
Knowland Technology Holdings, L.L.C.	Business Services	First Lien Term Loan 11.00% Cash, 11/29/2017	$	5,259,171		5,212,134		5,259,171		4.3	%
Vector Controls Holding Co., LLC (d)	Business Services	First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018	$	9,387,880		9,255,555		9,387,880		7.7	%
Vector Controls Holding Co., LLC (d), (g)	Business Services	Warrants to Purchase Limited Liability Company Interests		100		—		34,373		0.0	%

		Total Business Services				44,691,001		45,596,280		37.2	%

Targus Group International, Inc. (d)	Consumer Products	First Lien Term Loan 11.00% Cash, 5/24/2016	$	3,622,544		3,581,235		3,443,590		2.8	%
Targus Holdings, Inc. (d), (g)	Consumer Products	Common Stock		62,413		566,765		—		0.0	%
Targus Holdings, Inc. (d)	Consumer Products	Unsecured Note 10.00% PIK, 6/14/2019	$	2,054,158		2,054,158		1,473,654		1.2	%
Targus Holdings, Inc. (d)	Consumer Products	Unsecured Note 16.00% Cash, 10/26/2018	$	437,547		425,624		394,352		0.3	%

		Total Consumer Products				6,627,782		5,311,596		4.3	%

Avionte Holdings, LLC (g)	Consumer Services	Common Stock		100,000		100,000		142,000		0.1	%
Avionte Holdings, LLC	Consumer Services	First Lien Term Loan 8.25% Cash, 1/8/2019	$	3,000,000		2,948,818		3,000,000		2.5	%
CFF Acquisition L.L.C. (d)	Consumer Services	First Lien Term Loan 7.50% Cash, 7/31/2015	$	824,554		821,089		824,554		0.7	%
Expedited Travel L.L.C. (g)	Consumer Services	Common Stock		1,000,000		1,000,000		1,000,000		0.8	%
Expedited Travel L.L.C.	Consumer Services	First Lien Term Loan 10.00% Cash, 10/10/2019	$	14,000,000		13,845,224		14,000,000		11.4	%
PrePaid Legal Services, Inc. (d)	Consumer Services	First Lien Term Loan 6.25% Cash, 7/1/2019	$	3,870,968		3,839,277		3,870,968		3.2	%
PrePaid Legal Services, Inc. (d)	Consumer Services	Second Lien Term Loan 9.75% Cash, 7/1/2020	$	5,000,000		4,934,739		5,025,000		4.1	%

		Total Consumer Services				27,489,147		27,862,522		22.8	%

M/C Acquisition Corp., L.L.C. (d), (g)	Education	Class A Common Stock		544,761		30,241		—		0.0	%
M/C Acquisition Corp., L.L.C. (d)	Education	First Lien Term Loan 1.00% Cash, 3/31/2015	$	2,362,978		1,235,695		100,951		0.1	%

		Total Education				1,265,936		100,951		0.1	%

Group Dekko, Inc. (d)	Electronics	Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016	$	6,954,060		6,954,060		6,470,753		5.3	%

		Total Electronics				6,954,060		6,470,753		5.3	%


TB Corp. (d)	Food and Beverage	First Lien Term Loan 5.75% Cash, 6/19/2018	$	5,063,319	5,052,788	5,027,876	4.1	%
TB Corp. (d)	Food and Beverage	Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018	$	2,546,121	2,517,643	2,546,121	2.1	%
TM Restaurant Group L.L.C.	Food and Beverage	First Lien Term Loan 7.75% Cash, 7/16/2017	$	2,799,893	2,799,893	2,794,573	2.3	%

		Total Food and Beverage			10,370,324	10,368,570	8.5	%

Bristol Hospice, LLC	Healthcare Services	Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018	$	5,472,816	5,384,210	5,472,816	4.4	%
IDOC, LLC	Healthcare Services	First Lien Term Loan 9.75% Cash, 8/2/2017	$	13,644,083	13,659,669	13,644,083	11.1	%
Roscoe Medical, Inc. (d), (g)	Healthcare Services	Common Stock		5,000	500,000	190,500	0.2	%
Roscoe Medical, Inc.	Healthcare Services	Second Lien Term Loan 11.25% Cash, 9/26/2019	$	4,200,000	4,125,576	4,115,580	3.4	%
Smile Brands Group Inc. (d)	Healthcare Services	First Lien Term Loan 7.50% Cash, 8/16/2019	$	4,455,000	4,385,708	4,232,250	3.5	%
Surgical Specialties Corporation (US), Inc. (d)	Healthcare Services	First Lien Term Loan 7.25% Cash, 8/22/2018	$	2,343,750	2,325,095	2,320,312	1.9	%
Zest Holdings, LLC (d)	Healthcare Services	First Lien Term Loan 6.50% Cash, 8/16/2020	$	4,455,084	4,369,027	4,455,084	3.6	%

		Total Healthcare Services			34,749,285	34,430,625	28.1	%

Distribution International, Inc. (d)	Manufacturing	First Lien Term Loan 7.50% Cash, 7/16/2019	$	5,925,000	5,876,718	5,925,000	4.8	%

		Total Manufacturing			5,876,718	5,925,000	4.8	%

HMN Holdco, LLC	Media	First Lien Term Loan 14.00% Cash, 5/16/2019	$	9,438,047	9,267,197	9,343,666	7.6	%
HMN Holdco, LLC (g)	Media	Warrants to Purchase Limited Liability Company Interests (Common)		57,872	—	394,108	0.3	%
HMN Holdco, LLC (g)	Media	Warrants to Purchase Limited Liability Company Interests		8,139	—	106,214	0.1	%

		Total Media			9,267,197	9,843,988	8.0	%

Elyria Foundry Company, L.L.C. (d), (g)	Metals	Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 1/31/2015	$	8,859,616	8,859,614	6,020,268	4.9	%
Elyria Foundry Company, L.L.C. (d), (g)	Metals	Warrants to Purchase Limited Liability Company Interests (2008)		7,000	20	—	0.0	%
Elyria Foundry Company, L.L.C. (d), (g)	Metals	Warrants to Purchase Limited Liability Company Interests (2013)		18,227	—	—	0.0	%

		Total Metals			8,859,634	6,020,268	4.9	%

Network Communications, Inc. (d), (g)	Publishing	Common Stock		380,572	—	—	0.0	%
Network Communications, Inc. (d)	Publishing	Unsecured Notes 8.60% PIK, 1/14/2020	$	2,657,971	2,299,254	1,559,269	1.3	%

		Total Publishing			2,299,254	1,559,269	1.3	%

Censis Technologies, Inc.	Software	First Lien Term Loan B 11.00% Cash, 7/24/2019	$	11,925,000	11,695,936	11,925,000	9.7	%
Censis Technologies, Inc. (g), (h)	Software	Limited Partner Interests		999	999,000	999,000	0.8	%
Community Investors, Inc. (g)	Software	Common Stock		1,282	1,282	1,602	0.0	%
Community Investors, Inc.	Software	First Lien, Last Out Term Loan 11.83% Cash, 9/30/2019	$	12,000,000	12,000,000	12,000,000	9.8	%
Community Investors, Inc. (g)	Software	Preferred Stock		63,463	149,138	79,329	0.1	%
Community Investors, Inc. (g)	Software	Preferred Stock—A Shares		135,584	135,584	169,480	0.1	%
Finalsite Holdings, Inc.	Software	Second Lien Term Loan 10.25% Cash, 11/21/2019	$	7,500,000	7,425,157	7,500,000	6.2	%
Identity Automation Systems (g)	Software	Common Stock Class A Units		232,616	232,616	358,229	0.3	%
Identity Automation Systems	Software	First Lien Term Loan 10.25% Cash, 8/25/2019	$	4,500,000	4,456,885	4,500,000	3.7	%
Pen-Link, Ltd. (d)	Software	Second Lien Term Loan 12.50% Cash, 5/26/2019	$	11,500,000	11,302,271	11,500,000	9.5	%

		Total Software			48,397,869	49,032,640	40.2	%

Advanced Air & Heat of Florida, LLC	Utilities	First Lien Term Loan 10.00% Cash, 1/31/2019	$	6,105,441	6,026,036	6,105,441	5.0	%

		Total Utilities			6,026,036	6,105,441	5.0	%

Sub Total Non-control/Non-affiliated investments					222,452,952	221,740,190	181.3	%


Control investments—15.9% (b)
Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)	Structured Finance Securities	Other/Structured Finance Securities 17.89%, 10/17/2023	$	30,000,000		16,384,467		19,433,253	15.9	%

Sub Total Control investments						16,384,467		19,433,253	15.9	%

TOTAL INVESTMENTS—197.2% (b)					$	238,837,419	$	241,173,443	197.2	%

(a)	Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 8.1% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.

(b)	Percentages are based on net assets of $122,315,757 as of November 30, 2014.

(c)	Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).

(d)	These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).

(e)	This investment does not have a stated interest rate that is payable thereon. As a result, the 17.89% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.

(f)	As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:


Company	Purchases		Redemptions		Sales (cost)		Interest Income		Management fee income		Net Realized gains/(losses)		Net Unrealized gain
Saratoga Investment Corp. CLO 2013-1, Ltd.	$	—	$	—	$	—	$	1,996,010	$	1,150,505	$	—	$	3,048,786

(g)	Non-income producing at November 30, 2014.

(h)	Includes securities issued by an affiliate of the company.

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2014


Company	Industry	Investment Interest Rate / Maturity	Principal/ Number of Shares		Cost		Fair Value (c)		% of Net Assets
Non-control/Non-affiliated investments—162.1% (b)
PATS Aircraft, LLC	Aerospace	Common Stock		51,813	$	89,636	$	89,636		0.1	%
PATS Aircraft, LLC	Aerospace	First Lien Term Loan 8.50% Cash, 10/6/2016	$	254,598		254,598		254,598		0.2	%

		Total Aerospace				344,234		344,234		0.3	%

National Truck Protection Co., Inc. (d, g)	Automotive Aftermarket	Common Stock		1,116		1,000,000		1,152,531		1.0	%
National Truck Protection Co., Inc. (d)	Automotive Aftermarket	First Lien Term Loan 15.50% (13.50% Cash/2.00% PIK), 9/13/2018	$	8,250,000		8,250,000		8,250,000		7.2	%
Take 5 Oil Change, L.L.C. (d, g)	Automotive Aftermarket	Common Stock		7,128		712,800		1,217,747		1.1	%

		Total Automotive Aftermarket				9,962,800		10,620,278		9.3	%

Legacy Cabinets Holdings (d, g)	Building Products	Common Stock Voting A-1		2,535		220,900		552,351		0.5	%
Legacy Cabinets Holdings (d, g)	Building Products	Common Stock Voting B-1		1,600		139,424		348,624		0.3	%

		Total Building Products				360,324		900,975		0.8	%

ARSloane Acquistion, LLC	Business Services	First Lien Term Loan 7.50% Cash, 10/1/2019	$	997,500		988,200		1,004,981		0.9	%
BMC Software, Inc. (d)	Business Services	First Lien Term Loan 5.00% Cash, 9/10/2020	$	6,000,000		5,943,801		6,013,800		5.2	%
Dispensing Dynamics International (d)	Business Services	Senior Secured Note 12.50% Cash, 1/1/2018	$	7,000,000		6,882,278		7,525,000		6.5	%
Easy Ice, LLC (d)	Business Services	First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018	$	7,507,024		7,387,970		7,507,024		6.5	%
Emily Street Enterprises, L.L.C. (d)	Business Services	Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017	$	5,767,983		5,680,703		5,767,983		5.0	%
Emily Street Enterprises, L.L.C. (d, g)	Business Services	Warrant Membership Interests		49,318		400,000		601,679		0.5	%
Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)	Business Services	First Lien Term Loan 5.50% Cash, 6/28/2019	$	3,990,000		3,954,385		3,960,075		3.5	%
Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)	Business Services	Second Lien Term Loan 9.50% Cash, 6/28/2020	$	2,000,000		1,972,758		2,000,000		1.7	%
Knowland Technology Holdings, L.L.C. (d)	Business Services	First Lien Term Loan 11.00% Cash, 11/29/2017	$	6,200,000		6,107,034		6,200,000		5.4	%
Trinet HR Corporation (SOI Holdings, Inc.) (d)	Business Services	First Lien Term Loan 5.00% Cash, 8/20/2020	$	4,987,500		4,941,335		5,018,921		4.4	%
Trinet HR Corporation (SOI Holdings, Inc.) (d)	Business Services	Second Lien Term Loan 8.75% Cash, 2/20/2021	$	2,500,000		2,453,145		2,518,750		2.2	%
Vector Controls Holding Co., LLC (d)	Business Services	First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018	$	9,261,074		9,115,415		9,075,853		7.9	%
Vector Controls Holding Co., LLC (d, g)	Business Services	Warrants to Purchase Limited Liability Company Interests		101		—		136,217		0.1	%

		Total Business Services				55,827,024		57,330,283		49.8	%

Targus Group International, Inc. (d)	Consumer Products	First Lien Term Loan 11.00% Cash, 5/24/2016	$	3,738,369		3,704,766		3,663,602		3.2	%
Targus Holdings, Inc. (d, g)	Consumer Products	Common Stock		62,413		566,765		730,232		0.6	%
Targus Holdings, Inc. (d)	Consumer Products	Unsecured Note 10.00% PIK, 6/14/2019	$	2,054,158		2,054,158		1,387,848		1.2	%
Targus Holdings, Inc. (d)	Consumer Products	Unsecured Note 16.00% Cash, 10/26/2018	$	384,577		379,471		336,505		0.3	%

		Total Consumer Products				6,705,160		6,118,187		5.3	%

Avionte Holdings, LLC	Consumer Services	Common Stock	$	100,000		100,000		100,000		0.1	%
Avionte Holdings, LLC	Consumer Services	First Lien Term Loan 9.75% Cash, 1/8/2019	$	3,000,000		2,940,000		3,000,000		2.6	%
CFF Acquisition L.L.C. (d)	Consumer Services	First Lien Term Loan 7.50% Cash, 7/31/2015	$	1,319,891		1,273,596		1,319,891		1.1	%
Expedited Travel L.L.C. (d)	Consumer Services	First Lien Term Loan 9.00% Cash, 12/28/2017	$	4,580,000		4,501,104		4,580,000		4.0	%
PrePaid Legal Services, Inc. (d)	Consumer Services	First Lien Term Loan 6.25% Cash, 12/31/2016	$	4,274,194		4,236,035		4,247,694		3.7	%
PrePaid Legal Services, Inc. (d)	Consumer Services	Second Lien Term Loan 9.75% Cash, 7/1/2020	$	5,000,000		4,931,888		5,044,000		4.4	%

		Total Consumer Services				17,982,623		18,291,585		15.9	%


M/C Acquisition Corp., L.L.C. (d, g)	Education	Class A Common Stock		544,761	30,241	—	0.0	%
M/C Acquisition Corp., L.L.C. (d)	Education	First Lien Term Loan 1.00% Cash, 3/13/14	$	2,512,184	1,358,250	90,128	0.1	%

		Total Education			1,388,491	90,128	0.1	%

Group Dekko, Inc. (d)	Electronics	Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016	$	6,901,547	6,901,547	6,741,431	5.9	%

		Total Electronics			6,901,547	6,741,431	5.9	%

USS Parent Holding Corp. (d, g)	Environmental	Non Voting Common Stock		765	133,002	220,992	0.2	%
USS Parent Holding Corp. (d, g)	Environmental	Voting Common Stock		17,396	3,025,798	5,027,574	4.4	%

		Total Environmental			3,158,800	5,248,566	4.6	%

DS Waters of America, Inc. (d)	Food and Beverage	First Lien Term Loan 5.25% Cash, 8/30/2020	$	2,493,750	2,470,506	2,531,156	2.2	%
HOA Restaurant Group, L.L.C. (d)	Food and Beverage	Senior Secured Note 11.25% Cash, 4/1/2017	$	4,000,000	3,918,437	4,240,000	3.7	%
TB Corp. (d)	Food and Beverage	First Lien Term Loan 5.75% Cash, 6/19/2018	$	5,101,971	5,082,013	5,127,481	4.5	%
TB Corp. (d)	Food and Beverage	Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018	$	2,543,154	2,513,130	2,555,870	2.2	%
TM Restaurant Group L.L.C. (d)	Food and Beverage	First Lien Term Loan 7.75% Cash, 7/16/2017	$	2,845,690	2,831,271	2,831,462	2.5	%

		Total Food and Beverage			16,815,357	17,285,969	15.1	%

Bristol Hospice, LLC	Healthcare Services	Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018	$	5,509,782	5,405,325	5,509,782	4.8	%
Oceans Acquisition, Inc. (d)	Healthcare Services	First Lien Term A Loan 10.75% Cash, 12/27/2017	$	6,373,113	6,273,020	6,373,113	5.6	%
Oceans Acquisition, Inc. (d)	Healthcare Services	First Lien Term B Loan 10.75% Cash, 12/27/2017	$	500,000	490,224	500,000	0.4	%
Smile Brands Group Inc. (d)	Healthcare Services	First Lien Term Loan 7.50% Cash, 8/16/2019	$	4,488,750	4,406,559	4,488,750	3.9	%
Surgical Specialties Corporation (US), Inc. (d)	Healthcare Services	First Lien Term Loan 7.25% Cash, 8/22/2018	$	2,437,500	2,415,591	2,449,688	2.1	%
Zest Holdings, LLC (d)	Healthcare Services	First Lien Term Loan 6.50% Cash, 8/16/2020	$	4,488,750	4,405,073	4,488,750	3.9	%

		Total Healthcare Services			23,395,792	23,810,083	20.7	%

McMillin Companies L.L.C. (d, g, h)	Homebuilding	Senior Secured Note 0% Cash, 12/31/2013	$	550,000	558,434	344,355	0.3	%

		Total Homebuilding			558,434	344,355	0.3	%

Distribution International, Inc.. (d)	Manufacturing	First Lien Term Loan 7.50% Cash, 7/16/2019	$	5,970,000	5,916,094	5,970,000	5.2	%

		Total Manufacturing			5,916,094	5,970,000	5.2	%

Elyria Foundry Company, L.L.C. (d)	Metals	Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014	$	8,859,614	8,859,614	6,644,711	5.8	%
Elyria Foundry Company, L.L.C. (d, g)	Metals	Warrants to Purchase Limited Liability Company Interests (2008)		7,000	20	—	0.0	%
Elyria Foundry Company, L.L.C. (d, g)	Metals	Warrants to Purchase Limited Liability Company Interests (2013)		18,227	—	—	0.0	%

		Total Metals			8,859,634	6,644,711	5.8	%

Network Communications, Inc. (d, g)	Publishing	Common Stock		380,572	—	—	0.0	%
Network Communications, Inc. (d)	Publishing	Unsecured Notes 8.60% PIK, 1/14/2020	$	2,601,736	2,202,168	1,190,888	1.0	%

		Total Publishing			2,202,168	1,190,888	1.0	%

Community Investors, Inc. (d, g)	Software	Common Stock		1,282	1,282	1,449	0.0	%
Community Investors, Inc. (d)	Software	First Lien Term Loan 9.75% Cash, 5/9/2018	$	6,983,333	6,863,915	6,983,333	6.1	%
Community Investors, Inc. (d)	Software	Revolver	$	166,667	—	—	0.0	%
Community Investors, Inc. (d, g)	Software	Preferred Stock		135,584	135,584	153,210	0.1	%
Pen-Link, Ltd.	Software	Second Lien Term Loan 12.50% Cash, 5/26/2019	$	11,500,000	11,280,887	11,500,000	10.0	%

		Total Software			18,281,668	18,637,992	16.2	%


Advanced Air & Heat of Florida, LLC	Utilities	First Lien Term Loan 10.00% Cash, 1/31/2019	$	6,705,441		6,606,457		6,705,441	5.8	%

		Total Utilities				6,606,457		6,705,441	5.8	%

Sub Total Non-control/Non-affiliated investments						185,266,607		186,275,106	162.1	%

Control investments—17.0% (b)
Saratoga Investment Corp. CLO 2013-1, Ltd. (a) (d), (e), (f)	Structured Finance Securities	Other/Structured Finance Securities 15.16%, 10/17/2023	$	30,000,000		16,555,808		19,569,596	17.0	%

Sub Total Control investments						16,555,808		19,569,596	17.0	%

TOTAL INVESTMENTS—179.1% (b)					$	201,822,415	$	205,844,702	179.1	%

(a)	Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 8.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.

(b)	Percentages are based on net assets of $114,924,018 as of February 28, 2014.

(c)	Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).

(d)	These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).

(e)	This investment does not have a stated interest rate that is payable thereon. As a result, the 15.16% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.

(f)	As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:


Company	Purchases		Redemptions		Sales (cost)		Interest Income		Management fee income		Net Realized gains/(losses)		Net Unrealized gains/(losses)
Saratoga Investment Corp. CLO 2013-1, Ltd.	$	—	$	—	$	—	$	3,410,868	$	1,775,141	$	—	$	3,013,788

(g)	Non-income producing at February 28, 2014.

(h)	In connection with the restructuring of this investment, the Company agreed to forego the receipt of any interest payments thereon.

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)


	For the nine months ended November 30, 2014			For the nine months ended November 30, 2013
INCREASE FROM OPERATIONS:
Net investment income	$	6,842,936		$	7,639,588
Net realized gain from investments		3,203,399			1,157,824
Net unrealized depreciation on investments		(1,686,263	)		(3,770,968	)

Net increase in net assets from operations		8,360,072			5,026,444

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:
Distributions declared		(968,333	)		(12,534,807	)

Net decrease in net assets from shareholder distributions		(968,333	)		(12,534,807	)

CAPITAL SHARE TRANSACTIONS:
Stock dividend distribution		—			10,027,695

Net increase in net assets from capital share transactions		—			10,027,695


Total increase in net assets		7,391,739			2,519,332
Net assets at beginning of period		114,924,018			108,686,761

Net assets at end of period	$	122,315,757		$	111,206,093


Net asset value per common share	$	22.74		$	20.67

Common shares outstanding at end of period		5,379,616			5,379,616
Distribution in excess of net investment income	$	(23,752,974	)	$	(29,418,170	)

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)


	For the nine months ended November 30, 2014			For the nine months ended November 30, 2013
Operating activities
NET INCREASE IN NET ASSETS FROM OPERATIONS	$	8,360,072		$	5,026,444
ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:
Paid-in-kind interest income		(566,776	)		(634,408	)
Net accretion of discount on investments		(435,222	)		(543,999	)
Amortization of deferred debt financing costs		726,579			660,568
Net realized gain from investments		(3,203,399	)		(1,157,824	)
Net unrealized depreciation on investments		1,686,263			3,770,968
Proceeds from sale and redemption of investments		51,175,739			64,989,332
Purchase of investments		(83,985,346	)		(110,122,464	)
(Increase) decrease in operating assets:
Cash and cash equivalents, reserve accounts		(7,444,962	)		10,487,010
Interest receivable		(599,123	)		138,220
Due from manager		—			(4,929	)
Management fee receivable		(28,128	)		49,171
Other assets		5,878			(16,190	)
Receivable from unsettled trades		—			1,817,074
Increase (decrease) in operating liabilities:
Management and incentive fees payable		694,274			(922,261	)
Accounts payable and accrued expenses		(274,003	)		(53,553	)
Interest and debt fees payable		(147,834	)		256,537
Due to manager		(60,721	)		50,570

NET CASH USED BY OPERATING ACTIVITIES		(34,096,709	)		(26,209,734	)


Financing activities
Borrowings on debt		47,600,000			8,000,000
Paydowns on debt		(13,700,000	)		(24,300,000	)
Issuance of notes		—			48,300,000
Debt financing cost		(1,639,800	)		(2,579,308	)
Payments of cash dividends		(648,144	)		—

NET CASH PROVIDED BY FINANCING ACTIVITIES		31,612,056			29,420,692


NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(2,484,653	)		3,210,958
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		3,293,898			149,025

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	809,245		$	3,359,983


Supplemental information:
Interest paid during the period	$	4,887,477		$	3,425,552
Supplemental non-cash information:
Paid-in-kind interest income	$	566,776		$	634,408
Net accretion of discount on investments	$	435,222		$	543,999
Amortization of deferred debt financing costs	$	726,579		$	660,568
Stock dividend distribution	$	—		$	10,027,695
Cash dividend payable	$	—		$	2,507,112

See accompanying notes to consolidated financial statements.

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2014

(unaudited)

Note 1. Organization and Basis of Presentation

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.”.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant an investment advisory and management agreement dated July 30, 2010 (the “Management Agreement”). Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC) and SBIC LP. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

Note 2. Summary of Significant Accounting Policies

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

•

we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

•

we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

•

we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

•

Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

•

An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

•

The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

•

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in income when earned.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2014, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2011, 2012 and 2013 federal tax years for the Company remain subject to examination by the IRS. As of November 30, 2014 and February 28, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

New Accounting Pronouncements

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

•

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

•

Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

•

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of November 30, 2014 (dollars in thousands), according to the fair value hierarchy:


	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Syndicated loans	$	—	$	—	$	24,523	$	24,523
First lien term loans		—		—		120,627		120,627
Second lien term loans		—		—		36,601		36,601
Senior secured notes		—		—		24,791		24,791
Unsecured notes		—		—		5,973		5,973
Structured finance securities		—		—		19,433		19,433
Equity interest		—		—		9,225		9,225

Total	$	—	$	—	$	241,173	$	241,173

The following table presents fair value measurements of investments, by major class, as of February 28, 2014 (dollars in thousands), according to the fair value hierarchy:


	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Syndicated loans	$	—	$	—	$	32,390	$	32,390
First lien term loans		—		—		80,246		80,246
Second lien term loans		—		—		27,804		27,804
Senior secured notes		—		—		30,032		30,032
Unsecured notes		—		—		5,471		5,471
Structured finance securities		—		—		19,570		19,570
Equity interest		—		—		10,332		10,332

Total	$	—	$	—	$	205,845	$	205,845

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2014 (dollars in thousands):


	Syndicated loans			First lien term loans			Second lien term loans			Senior secured notes			Unsecured notes		Structured finance securities			Common stock/ equities			Total
Balance as of February 28, 2014	$	32,390		$	80,246		$	27,804		$	30,032		$	5,471	$	19,570		$	10,332		$	205,845
Net unrealized gains (losses)		(485	)		92			(379	)		(796	)		355		35			(508	)		(1,686	)
Purchases and other adjustments to cost		44			62,812			18,630			91			147		—			3,263			84,987
Sales and redemptions		(7,462	)		(23,027	)		(9,500	)		(4,788	)		—		(172	)		(6,227	)		(51,176	)
Net realized gains from investments		36			504			46			252			—		—			2,365			3,203

Balance as of November 30, 2014	$	24,523		$	120,627		$	36,601		$	24,791		$	5,973	$	19,433		$	9,225		$	241,173

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2013 (dollars in thousands):


	Syndicated loans			First lien term loans			Second lien term loans			Senior secured notes			Unsecured notes		Structured finance securities			Common stock/ equities			Total
Balance as of February 28, 2013	$	—		$	83,792		$	9,571		$	23,305		$	4,874	$	25,517		$	8,021		$	155,080
Net unrealized gains (losses)		396			(452	)		120			(23	)		339		(4,109	)		(42	)		(3,771	)
Purchases and other adjustments to cost		37,031			38,305			20,693			14,366			166		—			740			111,301
Sales and redemptions		(46	)		(51,667	)		(3,031	)		(7,728	)		—		(2,389	)		(128	)		(64,989	)
Net realized gains from investments		—			659			371			—			—		—			128			1,158

Balance as of November 30, 2013	$	37,381		$	70,637		$	27,724		$	29,920		$	5,379	$	19,019		$	8,719		$	198,779

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the nine months ended November 30, 2014 and 2013, on investments held as of November 30, 2014 and 2013, was $573,734 and $(3,890,205), respectively, and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2014 were as follows (dollars in thousands):


	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average Yield
Syndicated loans	$	24,523	Market Comparables	Third-Party Bid	95.0 - 100.0		98.6%
First lien term loans		120,627	Market Comparables	Market Yield (%)	5.5% - 15.6%		10.9%
				EBITDA Multiples (x)	3.0x		3.0x
				Third-Party Bid	83.7 - 100.0		92.3%
Second lien term loans		36,601	Market Comparables	Market Yield (%)	9.8% - 16.7%		12.3%
				Third-Party Bid	99.5 — 100.5		100.2%
Senior secured notes		24,791	Market Comparables	Market Yield (%)	11.0% - 12.0%		11.5%
				EBITDA Multiples (x)	5.0x		5.0x
				Third-Party Bid	107.0		107.0%
Unsecured notes		5,973	Market Comparables	Market Yield (%)	13.2% - 21.2%		17.0%
Structured finance securities		19,433	Discounted Cash Flow	Discount Rate (%)	10.0%		10.0%
Equity interests		9,225	Market Comparables	EBITDA Multiples (x)	2.2x — 11.1x		7.1x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2014 were as follows (dollars in thousands):


	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average Yield
Syndicated loans	$	32,390	Market Comparables	Third-Party Bid	99.5 - 100.6		100.1%
First lien term loans		80,246	Market Comparables	Market Yield (%)	5.1% - 15.5%		10.4%
				EBITDA Multiples (x)	3.0x		3.0x
				Third-Party Bid	83.3 - 101.5		97.0%
Second lien term loans		27,804	Market Comparables	Market Yield (%)	9.6% - 12.5%		11.7%
				Third-Party Bid	100.0 — 101.8		101.1%
Senior secured notes		30,032	Market Comparables	Market Yield (%)	11.0% - 42.5%		12.4%
				EBITDA Multiples (x)	5.0x		5.0x
				Third-Party Bid	106.0 - 107.5		107.0%
Unsecured notes		5,471	Market Comparables	Market Yield (%)	12.8% - 20.3%		16.5%
Structured finance securities		19,570	Discounted Cash Flow	Discount Rate (%)	9.0%		9.0%
Equity interests		10,332	Market Comparables	EBITDA Multiples (x)	6.3x — 12.0x		7.8x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of the Company’s investments as of November 30, 2014, at amortized cost and fair value were as follows (dollars in thousands):


	Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio
Syndicated loans	$	24,602		10.3	%	$	24,523		10.2	%
First lien term loans		121,024		50.7			120,627		50.0
Second lien term loans		36,716		15.4			36,601		15.2
Senior secured notes		26,859		11.2			24,791		10.3
Unsecured notes		7,297		3.0			5,973		2.5
Structured finance securities		16,384		6.9			19,433		8.0
Equity interest		5,955		2.5			9,225		3.8

Total	$	238,837		100.0	%	$	241,173		100.0	%

The composition of the Company’s investments as of February 28, 2014, at amortized cost and fair value were as follows (dollars in thousands):


	Investments at Amortized Cost		Amortized Cost Percentage of Total Portfolio			Investments at Fair Value		Fair Value Percentage of Total Portfolio
Syndicated loans	$	31,983		15.8	%	$	32,390		15.7	%
First lien term loans		80,734		40.0			80,246		39.0
Second lien term loans		27,540		13.6			27,804		13.5
Senior secured notes		31,304		15.6			30,032		14.6
Unsecured notes		7,149		3.5			5,471		2.7
Structured finance securities		16,556		8.2			19,570		9.5
Equity interest		6,556		3.3			10,332		5.0

Total	$	201,822		100.0	%	$	205,845		100.0	%

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing

investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2014. The significant inputs for the valuation model include:

•

Default rates: 2.0%

•

Recovery rates: 35-75%

•

Prepayment rate: 25.0%

•

Reinvestment rate / price: L+375bps / $99.75

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services — Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the quarterly period ended November 30, 2014.

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the three months ended November 30, 2014 and November 30, 2013, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.7 million and $0.6 million in interest income, respectively, from Saratoga CLO. For the nine months ended November 30, 2014 and November 30, 2013, we accrued $1.2 million and $1.4 million in management fee income, respectively, and $2.0 million and $2.8 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At November 30, 2014, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $19.4 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2014, Saratoga CLO had investments with a principal balance of $302.6 million and a weighted average spread over LIBOR of 4.2%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2014, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $23.7 million, which had a present value of approximately $19.8 million, using a 10.0% discount rate.

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of November 30, 2014 and February 28, 2014, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the three and nine months ended November 30, 2014 and November 30, 2013.

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities


	As of
	November 30, 2014			February 28, 2014
	(unaudited)
ASSETS
Investments
Fair value loans (amortized cost of $300,731,616 and $299,137,566, respectively)	$	297,038,596		$	300,491,077

Total investments at fair value (amortized cost of $300,731,616 and $299,137,566, respectively)		297,038,596			300,491,077
Cash and cash equivalents		1,942,404			8,018,933
Receivable from open trades		6,091,525			1,801,266
Interest receivable		1,437,136			1,450,952
Deferred debt financing costs, net		1,997,854			2,166,633
Other assets		91,335			91,336

Total assets	$	308,598,850		$	314,020,197


LIABILITIES
Interest payable	$	666,488		$	622,476
Payable from open trades		8,536,209			9,445,000
Accrued base management fee		89,117			75,053
Accrued subordinated management fee		89,117			75,053
Class X Notes - SIC CLO 2013-1, Ltd.		—			1,666,666
Class A-1 Notes - SIC CLO 2013-1, Ltd.		170,000,000			170,000,000
Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.		(1,539,214	)		(1,671,864	)
Class A-2 Notes - SIC CLO 2013-1, Ltd.		20,000,000			20,000,000
Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.		(159,550	)		(173,300	)
Class B Notes - SIC CLO 2013-1, Ltd.		44,800,000			44,800,000
Discount on Class B Notes - SIC CLO 2013-1, Ltd.		(1,036,437	)		(1,125,757	)
Class C Notes - SIC CLO 2013-1, Ltd.		16,000,000			16,000,000
Discount on Class C Notes - SIC CLO 2013-1, Ltd.		(645,291	)		(700,902	)
Class D Notes - SIC CLO 2013-1, Ltd.		14,000,000			14,000,000
Discount on Class D Notes - SIC CLO 2013-1, Ltd.		(837,638	)		(909,825	)
Class E Notes - SIC CLO 2013-1, Ltd.		13,100,000			13,100,000
Discount on Class E Notes - SIC CLO 2013-1, Ltd.		(1,579,190	)		(1,715,285	)
Class F Notes - SIC CLO 2013-1, Ltd.		4,500,000			4,500,000
Discount on Class F Notes - SIC CLO 2013-1, Ltd.		(574,380	)		(623,880	)
Subordinated Notes		30,000,000			30,000,000

Total liabilities	$	315,409,231		$	317,363,435

Commitments and contingencies
NET ASSETS
Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively	$	250		$	250
Accumulated gain/(loss)		(3,343,489	)		838,567
Net loss		(3,467,142	)		(4,182,055	)

Total net assets		(6,810,381	)		(3,343,238	)


Total liabilities and net assets	$	308,598,850		$	314,020,197

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)


	For the three months ended November 30						For the nine months ended November 30
	2014			2013			2014			2013
INVESTMENT INCOME
Interest from investments	$	3,353,937		$	3,552,429		$	9,834,775		$	12,160,257
Interest from cash and cash equivalents		344			2,030			1,182			6,481
Other income		55,362			214,092			196,292			891,358

Total investment income		3,409,643			3,768,551			10,032,249			13,058,096


EXPENSES
Interest expense		2,831,770			6,906,431			6,955,909			9,944,427
Professional fees		43,547			62,452			137,907			387,380
Miscellaneous fee expense		6,734			4,198			33,130			164,989
Base management fee		191,505			134,244			575,252			330,012
Subordinated management fee		191,505			286,953			575,252			1,070,026
Trustee expenses		36,314			21,012			90,242			69,383
Amortization expense		237,966			3,692,220			717,892			4,201,074

Total expenses		3,539,341			11,107,510			9,085,584			16,167,291


NET INVESTMENT INCOME (LOSS)		(129,698	)		(7,338,959	)		946,665			(3,109,195	)

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:
Net realized gain/(loss) on investments		104,158			(9,292,595	)		632,728			(8,840,995	)
Net unrealized appreciation/(depreciation) on investments		(2,167,924	)		10,367,981			(5,046,535	)		6,868,170

Net gain/(loss) on investments		(2,063,766	)		1,075,386			(4,413,807	)		(1,972,825	)


NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	(2,193,464	)	$	(6,263,573	)	$	(3,467,142	)	$	(5,082,020	)

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

November 30, 2014

(unaudited)


Issuer Name	Industry	Asset Name	Asset Type	Current Rate			Maturity Date		Principal		Cost		Fair Value
24 Hour Holdings III LLC	Leisure Goods/Activities/Movies	Term Loan	Loan		3.75	%		5/28/2021	$	498,750	$	494,092	$	492,206
Acosta Holdco Inc.	Media	Term Loan B	Loan		5.00	%		8/13/2021		2,000,000		1,985,464		2,005,320
Aderant North America, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		5.25	%		12/20/2018		3,260,898		3,260,898		3,228,289
Advantage Sales & Marketing Inc.	Business Equipment and Services	Term Loan	Loan		4.25	%		7/25/2021		64,516		64,536		63,847
Advantage Sales & Marketing Inc.	Business Equipment and Services	Delayed Draw Term Loan	Loan		4.25	%		7/25/2021		1,935,484		1,934,254		1,915,432
AECOM Technology Corporation	Business Equipment and Services	Term Loan B	Loan		3.75	%		10/15/2021		319,903		318,328		320,303
Aegis Toxicology Science Corporation	Healthcare	Term B Loan	Loan		5.50	%		2/24/2021		997,500		997,500		997,500
Akorn, Inc.	Healthcare	Term Loan B	Loan		4.50	%		4/16/2021		500,000		497,853		501,250
Albertson’s LLC	Retailers (Except Food and Drugs)	Term Loan B-4	Loan		5.50	%		8/25/2021		410,000		407,969		409,827
Albertson’s LLC	Retailers (Except Food and Drugs)	Term Loan B-4	Loan		5.50	%		8/25/2021		3,000,000		2,981,665		2,998,740
Alere Inc. (fka IM US Holdings, LLC)	Healthcare	Incremental B-1 Term Loan	Loan		4.25	%		6/30/2017		1,944,987		1,944,987		1,938,296
American Tire Distributors Inc	Automotive	Term Loan	Loan		5.75	%		6/1/2018		497,738		497,738		496,806
Anchor Glass	Containers/Glass Products	Term Loan	Loan		3.25	%		5/16/2021		2,000,000		1,995,153		1,986,500
Applied Systems, Inc.	Business Equipment and Services	Initial Term Loan (First Lien)	Loan		4.25	%		1/25/2021		496,250		495,146		493,521
Aramark Corporation	Food Products	LC-2 Facility	Loan		3.69	%		7/26/2016		79,187		79,180		78,494
Aramark Corporation	Food Products	LC-3 Facility	Loan		3.69	%		7/26/2016		43,961		43,961		43,576
Aramark Corporation	Food Products	U.S. Term F Loan	Loan		3.25	%		2/24/2021		3,190,505		3,190,505		3,145,965
ARG IH Corp	Food Services	Term Loan	Loan		4.75	%		11/15/2020		496,250		495,221		496,126
Asurion, LLC (fka Asurion Corporation)	Insurance	Incremental Tranche B-1 Term Loan	Loan		5.00	%		5/24/2019		5,452,971		5,408,975		5,427,069
Auction.Com, LLC	Business Equipment and Services	Term Loan A-4	Loan		4.40	%		2/28/2017		914,567		914,567		905,422
Avantor Performance Materials Holdings, Inc.	Chemicals/Plastics	Term Loan	Loan		5.25	%		6/26/2017		4,319,115		4,308,260		4,297,520
Avast Software	Electronics/Electric	Term Loan	Loan		4.00	%		3/20/2020		1,950,000		1,947,791		1,945,125
AZ Chem US Inc.	Chemicals/Plastics	Term Loan	Loan		5.25	%		12/22/2017		478,767		476,432		476,972
Bass Pro Group, LLC	Retailers (Except Food and Drugs)	New Term Loan	Loan		3.75	%		11/20/2019		494,899		494,382		491,805
Bayonne Energy Center	Oil & Gas	Term Loan B	Loan		4.50	%		8/19/2021		982,343		977,524		984,494
Belmond Hotels	Lodging & Casinos	Term Loan	Loan		4.00	%		3/19/2021		497,500		495,181		492,938
Berry Plastics Corporation	Chemicals/Plastics	Term E Loan	Loan		3.75	%		1/6/2021		1,814,499		1,801,846		1,786,465
Big Heart Pet Brands (fka Del Monte Corporation)	Food/Drug Retailers	Initial Term Loan	Loan		3.50	%		3/9/2020		2,985,000		3,004,996		2,880,525
Biomet, Inc.	Healthcare	Dollar Term B-2 Loan	Loan		3.65	%		7/25/2017		1,840,718		1,840,718		1,836,116
BJ’s Wholesale Club, Inc.	Food/Drug Retailers	New 2013 (November) Replacement Loan (First Lien)	Loan		4.50	%		9/26/2019		1,493,737		1,492,618		1,482,953
Bombardier Recreational Products Inc.	Leisure Goods/Activities/Movies	Term B Loan	Loan		4.00	%		1/30/2019		754,286		750,056		746,509
Brickman Group Holdings, Inc.	Brokers/Dealers/Investment Houses	Initial Term Loan (First Lien)	Loan		4.00	%		12/18/2020		1,494,994		1,482,074		1,477,143
Brock Holdings III, Inc.	Industrial Equipment	Term Loan (First Lien)	Loan		6.00	%		3/16/2017		1,943,837		1,959,132		1,846,645
Burlington Coat Factory Warehouse Corporation	Retailers (Except Food and Drugs)	Term B-2 Loan	Loan		4.25	%		2/23/2017		1,995,000		1,985,325		1,985,025
BWAY	Leisure Goods/Activities/Movies	Term Loan B	Loan		5.50	%		8/14/2020		997,500		987,910		998,747
Caesars Entertainment Corp.	Lodging & Casinos	Term B-7 Loan	Loan		6.25	%		3/1/2017		997,500		991,102		915,206
Camp International Holding Company	Aerospace and Defense	2013 Replacement Term Loan (First Lien)	Loan		4.75	%		5/31/2019		1,965,034		1,970,857		1,969,947
Capital Automotive L.P.	Conglomerate	Tranche B-1 Term Loan Facility	Loan		4.00	%		4/10/2019		2,084,879		2,089,597		2,079,021
Catalent Pharma Solutions, Inc	Drugs	Initial Term B Loan	Loan		3.50	%		9/15/2021		498,750		496,327		498,660
Celanese US Holdings LLC	Chemicals/Plastics	Dollar Term C-2 Commitment	Loan		2.25	%		10/31/2016		2,159,974		2,187,537		2,159,585
Cengage Learning	Publishing	Term Loan	Loan		7.00	%		3/31/2020		2,738,750		2,769,924		2,737,901
Charter Communications Operating, LLC	Cable and Satellite Television	Term F Loan	Loan		3.00	%		12/31/2020		2,662,486		2,653,171		2,624,226
CHS/Community Health Systems, Inc.	Healthcare	2017 Term E Loan	Loan		3.48	%		1/25/2017		1,100,591		1,074,787		1,098,390
CHS/Community Health Systems, Inc.	Healthcare	2021 Term D Loan	Loan		4.25	%		1/27/2021		2,933,441		2,849,143		2,936,492
Cinedigm Digital Funding I, LLC	Business Equipment and Services	Term Loan	Loan		3.75	%		2/28/2018		633,604		628,590		632,020
CITGO Petroleum	Oil & Gas	Term Loan B	Loan		4.50	%		7/29/2021		1,000,000		996,338		995,000
ClubCorp Club Operations, Inc.	Lodging & Casinos	Term Loan B	Loan		4.50	%		7/24/2020		500,000		496,250		498,125
Covanta Energy Corporation	Ecological Services and Equipment	Term Loan	Loan		3.25	%		3/28/2019		330,833		329,802		329,732
CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)	Electronics/Electric	Term B Loan	Loan		4.25	%		4/7/2021		3,604,388		3,604,388		3,562,324
Crosby US Acquisition Corp.	Industrial Equipment	Initial Term Loan (First Lien)	Loan		4.00	%		11/23/2020		744,375		743,561		716,461
Crown Castle Operating Company	Telecommunications/Cellular	Extended Incremental Tranche B-2 Term Loan	Loan		3.00	%		1/31/2021		2,441,744		2,439,592		2,431,074
CT Technologies Intermediate Hldgs, Inc	Healthcare	Term Loan (First Lien)	Loan		6.00	%		11/18/2021		1,500,000		1,485,000		1,492,500
Culligan International Company	Conglomerate	Dollar Loan (First Lien)	Loan		6.25	%		12/19/2017		783,162		729,780		732,257
Culligan International Company	Conglomerate	Dollar Loan (Second Lien)	Loan		9.50	%		6/19/2018		781,646		734,775		763,410
Cumulus Media Holdings Inc.	Broadcast Radio and Television	Term Loan	Loan		4.25	%		12/23/2020		482,438		478,143		474,599
Custom Sensors	Industrial Equipment	Term Loan	Loan		4.50	%		6/18/2021		500,000		498,799		498,750
DaVita HealthCare Partners Inc. (fka DaVita Inc.)	Healthcare	Tranche B Term Loan	Loan		4.50	%		10/20/2016		498,750		496,393		495,842
DCS Business Services, Inc.	Financial Intermediaries	Term B Loan	Loan		7.25	%		3/19/2018		3,468,917		3,443,130		3,418,930
Dealertrack Technologies, Inc.	Leisure Goods/Activities/Movies	Term B Loan	Loan		3.50	%		2/26/2021		477,011		475,946		471,645
Dell International LLC	Retailers (Except Food and Drugs)	Term B Loan	Loan		4.50	%		4/29/2020		2,977,481		2,964,580		2,979,595
Delos Finance SARL	Financial Intermediaries	Term Loan	Loan		3.50	%		3/6/2021		500,000		497,709		498,125
Delta 2 (Lux) S.a.r.l.	Lodging & Casinos	Term Loan B-3	Loan		4.75	%		7/30/2021		1,000,000		995,106		986,750
Deluxe Entertainment Service Group, Inc.	Leisure Goods/Activities/Movies	Term Loan (First Lien)	Loan		6.50	%		2/28/2020		1,981,211		1,982,485		1,812,808
Devix US, Inc.	Chemicals/Plastics	Term Loan	Loan		4.25	%		4/30/2021		250,000		247,654		247,500
Devix US, Inc.	Chemicals/Plastics	Term Loan (Second Lien)	Loan		8.00	%		5/2/2022		498,750		496,400		497,089
Diamond Resorts International	Lodging & Casinos	Term Loan	Loan		5.50	%		5/9/2021		997,500		992,639		999,994
DPX Holdings B.V.	Healthcare	Term Loan	Loan		4.25	%		3/11/2021		2,992,500		2,985,464		2,920,889
Drew Marine Group Inc.	Chemicals/Plastics	Term Loan (First Lien)	Loan		4.50	%		11/19/2020		1,493,737		1,499,009		1,476,933
Dunkin’ Brands, Inc.	Food Services	Term B-4 Loan	Loan		3.25	%		2/7/2021		3,942,384		3,933,806		3,870,593
Education Management LLC	Leisure Goods/Activities/Movies	Tranche C-2 Term Loan	Loan		4.25	%		6/1/2016		3,905,338		3,818,145		1,732,994
EIG Investors Corp.	Business Equipment and Services	Term Loan	Loan		5.00	%		11/8/2019		990,000		985,855		990,000
Emerald Performance Materials, LLC	Chemicals/Plastics	Term Loan (First Lien)	Loan		4.50	%		8/1/2021		500,000		497,576		495,940
Emerald Performance Materials, LLC	Chemicals/Plastics	Term Loan (Second Lien)	Loan		7.75	%		8/1/2022		500,000		497,511		491,875
EnergySolutions, LLC	Oil & Gas	Term Loan B	Loan		6.75	%		5/29/2020		997,500		979,024		1,004,981
Enviromental Resources Management	Business Equipment and Services	Term Loan	Loan		5.00	%		5/16/2021		1,000,000		990,000		995,830
Evergreen Acqco 1 LP	Retailers (Except Food and Drugs)	New Term Loan	Loan		5.00	%		7/9/2019		977,550		975,180		974,500
EWT Holdings III Corp. (fka WTG Holdings III Corp.)	Industrial Equipment	Term Loan (First Lien)	Loan		4.75	%		1/15/2021		1,992,500		1,986,969		1,980,047
Federal-Mogul Corporation	Automotive	Tranche C Term Loan	Loan		4.75	%		4/15/2021		2,992,500		2,978,941		2,983,612
First Data Corporation	Financial Intermediaries	2017 Second New Dollar Term Loan	Loan		4.15	%		3/24/2017		2,790,451		2,724,831		2,749,766
First Data Corporation	Financial Intermediaries	2018 Dollar Term Loan	Loan		4.15	%		3/23/2018		2,111,028		2,018,373		2,098,362
Fitness International, LLC	Leisure Goods/Activities/Movies	Term Loan B	Loan		5.50	%		7/1/2020		1,496,250		1,485,504		1,470,694
FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)	Nonferrous Metals/Minerals	Loan	Loan		3.75	%		6/28/2019		1,987,481		1,987,131		1,848,775
Four Seasons Holdings Inc.	Lodging & Casinos	Term Loan (First Lien)	Loan		3.50	%		6/29/2020		495,000		495,000		490,877
Garda World Security Corporation	Business Equipment and Services	Term B Delayed Draw Loan	Loan		4.00	%		11/6/2020		201,667		200,778		198,894
Garda World Security Corporation	Business Equipment and Services	Term B Loan	Loan		4.00	%		11/6/2020		788,333		784,955		777,494
Gardner Denver, Inc.	Oil & Gas	Initial Dollar Term Loan	Loan		4.25	%		7/30/2020		2,482,481		2,473,377		2,379,036
Gates Global LLC	Leisure Goods/Activities/Movies	Term Loan (First Lien)	Loan		4.25	%		7/2/2021		500,000		495,000		494,500
Generac Power Systems, Inc.	Industrial Equipment	Term Loan B	Loan		3.25	%		5/29/2020		821,138		807,233		799,239
General Nutrition Centers, Inc.	Retailers (Except Food and Drugs)	Amended Tranche B Term Loan	Loan		3.25	%		3/4/2019		4,728,130		4,712,615		4,606,003
Global Tel*Link Corporation	Business Equipment and Services	Term Loan (First Lien)	Loan		5.00	%		5/26/2020		2,763,065		2,754,287		2,738,888
Goodyear Tire & Rubber Company, The	Chemicals/Plastics	Loan (Second Lien)	Loan		4.75	%		4/30/2019		4,000,000		3,953,800		4,011,240
Grosvenor Capital Management Holdings, LP	Brokers/Dealers/Investment Houses	Initial Term Loan	Loan		3.75	%		1/4/2021		3,473,750		3,457,879		3,404,275
GTCR Valor Companies, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		6.00	%		6/1/2021		2,000,000		1,960,000		1,947,500
Harland Clarke Holdings Corp. (fka Clarke American Corp.)	Publishing	Tranche B-4 Term Loan	Loan		6.00	%		8/2/2019		490,625		488,469		491,699
HCA Inc.	Healthcare	Tranche B-4 Term Loan	Loan		2.94	%		5/1/2018		5,677,343		5,404,594		5,652,533
Hertz Corporation, The	Automotive	Tranche B-1 Term Loan	Loan		3.75	%		3/12/2018		2,947,500		2,985,385		2,909,418
Hoffmaster Group, Inc.	Containers/Glass Products	Term Loan	Loan		5.25	%		5/8/2020		1,995,000		1,976,131		1,987,519
Hologic, Inc.	Healthcare	Refinancing Tranche A Term Loan	Loan		2.15	%		8/1/2017		2,187,500		2,183,274		2,168,359
Huntsman International LLC	Chemicals/Plastics	Extended Term B Loan	Loan		2.69	%		4/19/2017		3,880,270		3,859,264		3,841,468
Husky Injection	Business Equipment and Services	Term Loan B	Loan		4.25	%		6/30/2021		498,099		495,778		491,125
Ikaria, Inc.	Healthcare	Initial Term Loan (First Lien)	Loan		5.00	%		2/12/2021		470,660		468,542		471,366
Infor (US), Inc. (fka Lawson Software Inc.)	Business Equipment and Services	Tranche B-5 Term Loan	Loan		3.75	%		6/30/2020		2,216,721		2,198,833		2,181,896
J. Crew Group, Inc.	Retailers (Except Food and Drugs)	Term B-1 Loan Retired 03/05/2014	Loan		4.00	%		3/5/2021		967,638		967,638		917,843
Jazz Acquisition, Inc	Aerospace and Defense	First Lien 6/14	Loan		4.50	%		6/19/2021		498,788		497,541		495,985
Kinetic Concepts, Inc.	Healthcare	Dollar Term D-1 Loan	Loan		4.00	%		5/4/2018		2,483,869		2,457,922		2,470,407
Koosharem, LLC	Business Equipment and Services	Term Loan	Loan		7.50	%		4/29/2020		997,500		990,756		982,537
La Quinta Holdings, Inc.	Lodging & Casinos	Term Loan (First Lien)	Loan		4.00	%		4/14/2021		461,938		460,169		459,281
Level 3 Financing, Inc.	Telecommunications	Term Loan B	Loan		4.50	%		1/31/2022		500,000		496,286		501,095
Mauser Holdings, Inc.	Containers/Glass Products	Term Loan	Loan		4.50	%		8/2/2021		500,000		497,582		496,875
Michaels Stores, Inc.	Retailers (Except Food and Drugs)	Term B Loan	Loan		3.75	%		1/28/2020		492,500		492,500		487,851
Michaels Stores, Inc.	Retailers (Except Food and Drugs)	Term Loan B-2	Loan		3.75	%		1/28/2020		1,496,250		1,489,059		1,489,307
Microsemi Corporation	Electronics/Electric	Incremental Term Loan	Loan		3.50	%		2/19/2020		2,393,981		2,389,500		2,365,852
Microsemi Corporation	Electronics/Electric	Term Loan	Loan		3.75	%		2/19/2020		172,170		172,170		170,591
Midas Intermediate Holdco II, LLC	Automotive	Delayed Draw Term Loan	Loan		4.75	%		8/18/2021		25,316		25,316		25,356
Midas Intermediate Holdco II, LLC	Automotive	Term Loan B	Loan		4.75	%		8/18/2021		224,683		223,579		225,034
Millenium Laboratories, LLC	Drugs	Term Loan	Loan		5.25	%		4/16/2021		1,496,250		1,482,301		1,498,120
Mitel US Holdings, Inc.	Telecommunications	Term Loan	Loan		5.25	%		1/31/2020		214,164		213,211		214,164
MPH Acquisition Holdings LLC	Health Insurance	Term Loan	Loan		4.00	%		3/31/2021		463,636		462,528		455,773
MSC Software Corp.	Business Equipment and Services	Term Loan	Loan		4.00	%		5/29/2020		997,500		988,304		996,253
National CineMedia, LLC	Leisure Goods/Activities/Movies	Term Loan (2013)	Loan		2.95	%		11/26/2019		1,086,207		1,057,633		1,038,457
National Veterinary Associates, Inc	Healthcare	Term Loan B	Loan		4.75	%		8/14/2021		1,000,000		995,200		998,750
National Vision, Inc.	Retailers (Except Food and Drugs)	Term Loan (Second Lien)	Loan		6.75	%		3/11/2022		250,000		249,723		232,500
Newsday, LLC	Publishing	Term Loan	Loan		3.69	%		10/12/2016		2,215,385		2,214,135		2,198,769
Nortek, Inc.	Electronics/Electric	Term B Loan	Loan		3.75	%		10/30/2020		997,500		995,116		986,278
Novelis, Inc.	Conglomerate	Initial Term Loan	Loan		3.75	%		3/10/2017		4,820,028		4,831,154		4,807,978
NPC International, Inc.	Food Services	Term Loan (2013)	Loan		4.00	%		12/28/2018		487,500		487,500		468,000
NRG Energy, Inc.	Utilities	Term Loan (2013)	Loan		2.75	%		7/2/2018		3,871,050		3,850,443		3,822,662
NuSil Technology LLC.	Chemicals/Plastics	Term Loan	Loan		5.25	%		4/7/2017		800,222		800,222		791,971
OEP Pearl Dutch Acquisition B.V.	Chemicals/Plastics	Initial BV Term Loan	Loan		6.50	%		3/30/2018		136,022		134,681		135,938
Ollie’s Bargain Outlet, Inc	Retailers (Except Food and Drugs)	Term Loan	Loan		6.00	%		9/30/2019		979,576		975,079		969,781
On Assignment, Inc.	Business Equipment and Services	Initial Term B Loan	Loan		3.50	%		5/15/2020		1,311,364		1,303,108		1,298,250
Onex Carestream Finance LP	Healthcare	Term Loan (First Lien 2013)	Loan		5.00	%		6/7/2019		4,226,014		4,209,392		4,226,902
OnexYork Acquisition Co	Healthcare	Delayed Draw Term Loan	Loan		5.00	%		6/7/2019		—		—		—
OnexYork Acquisition Co	Healthcare	Term Loan B	Loan		5.00	%		6/7/2019		451,220		447,878		448,719
OpenLink International LLC	Business Equipment and Services	Term B Loan	Loan		6.25	%		10/27/2017		972,500		972,500		967,638
Orbitz Worldwide, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		4.50	%		4/15/2021		1,498,750		1,496,379		1,492,006
P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)	Food/Drug Retailers	Term Borrowing	Loan		4.25	%		6/24/2019		1,451,689		1,444,063		1,409,953
P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)	Business Equipment and Services	Term Loan (First Lien)	Loan		5.00	%		10/30/2020		992,500		987,689		977,613
Paragon Offshore Finance	Oil & Gas	Term Loan B	Loan		3.75	%		7/18/2021		750,000		746,250		638,123
PetCo Animal Supplies Stores, Inc.	Retailers (Except Food and Drugs)	New Loans	Loan		4.00	%		11/24/2017		1,473,214		1,472,253		1,465,229
PGX Holdings, Inc.	Financial Intermediaries	Term Loan	Loan		6.25	%		9/9/2020		1,000,000		990,357		993,750
Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)	Conglomerate	2013 Term Loan	Loan		4.00	%		12/5/2018		1,945,350		1,921,827		1,939,105
Phillips-Medisize Corporation	Healthcare	Term Loan	Loan		4.75	%		6/16/2021		498,750		496,414		498,127
Pinnacle Foods Finance LLC	Food Products	New Term Loan G	Loan		3.25	%		4/29/2020		2,581,332		2,576,266		2,541,399
Planet Fitness Holdings LLC	Leisure Goods/Activities/Movies	Term Loan	Loan		4.75	%		3/31/2021		1,492,500		1,485,577		1,485,038
Polymer Group, Inc.	Chemicals/Plastics	Initial Loan	Loan		5.25	%		12/19/2019		496,250		493,975		496,870
Prestige Brands, Inc.	Drugs	Term B-1 Loan	Loan		3.75	%		1/31/2019		390,152		385,864		390,152
Prestige Brands, Inc.	Leisure Goods/Activities/Movies	Term Loan	Loan		4.50	%		9/3/2021		1,972,222		1,968,727		1,982,083
Progressive Waste Solutions Ltd.	Ecological Services and Equipment	Term B Loan	Loan		3.00	%		10/24/2019		494,962		494,962		496,407
QoL Meds, LLC	Healthcare	Term Loan B	Loan		5.50	%		7/15/2020		2,000,000		1,990,530		1,990,000
Quintiles Transnational Corp.	Conglomerate	Term B-3 Loan	Loan		3.75	%		6/8/2018		3,672,340		3,642,784		3,652,840
Ranpak Holdings, Inc.	Business Equipment and Services	Term Loan	Loan		4.75	%		10/1/2021		1,000,000		997,539		996,250
Ranpak Holdings, Inc.	Business Equipment and Services	Term Loan (Second Lien)	Loan		8.25	%		9/30/2022		500,000		497,617		499,585
Redtop Acquisitions Limited	Electronics/Electric	Initial Dollar Term Loan (First Lien)	Loan		4.50	%		12/3/2020		496,250		493,090		495,009
Rexnord LLC/RBS Global, Inc.	Industrial Equipment	Term B Loan	Loan		4.00	%		8/21/2020		1,650,968		1,652,341		1,637,893
Reynolds Group Holdings Inc.	Industrial Equipment	Incremental U.S. Term Loan	Loan		4.00	%		12/1/2018		1,965,150		1,965,150		1,955,501
Rocket Software, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		5.75	%		2/8/2018		1,916,674		1,897,240		1,916,674
Rovi Solutions Corporation / Rovi Guides, Inc.	Electronics/Electric	Tranche B-3 Term Loan	Loan		3.50	%		3/29/2019		1,496,250		1,489,116		1,471,472
RPI Finance Trust	Drugs	Term B-2 Term Loan	Loan		3.25	%		5/9/2018		5,220,614		5,199,989		5,198,844
SBP Holdings LP	Industrial Equipment	Term Loan (First Lien)	Loan		5.00	%		3/27/2021		995,000		990,400		965,150
Scientific Games International, Inc.	Electronics/Electric	Term Loan B2	Loan		6.00	%		10/1/2021		1,000,000		990,176		983,630
Scitor Corporation	Business Equipment and Services	Term Loan	Loan		5.00	%		2/15/2017		463,977		462,198		458,758
Seadrill	Oil & Gas	Term Loan B	Loan		4.00	%		2/21/2021		1,000,000		917,500		870,710
Sensata Technologies B.V./Sensata Technology Finance Company, LLC	Industrial Equipment	Term Loan	Loan		3.25	%		5/13/2019		1,513,266		1,513,266		1,513,266
Sensus USA Inc. (fka Sensus Metering Systems)	Utilities	Term Loan (First Lien)	Loan		4.75	%		5/9/2017		1,930,054		1,925,009		1,886,628
ServiceMaster Company, The	Conglomerate	Tranche B Term Loan	Loan		4.40	%		1/31/2017		2,000,000		1,980,986		1,984,500
Shearers Foods LLC	Food Services	Term Loan (First Lien)	Loan		4.50	%		6/30/2021		1,000,000		997,512		996,880
Sonneborn, LLC	Chemicals/Plastics	Initial US Term Loan	Loan		5.50	%		12/10/2020		770,792		759,038		770,314
Sophia, L.P.	Electronics/Electric	Term B Loan	Loan		4.00	%		7/19/2018		888,561		879,534		882,786
SourceHOV LLC	Business Equipment and Services	Term Loan B (First Lien)	Loan		7.75	%		10/31/2019		2,000,000		1,940,000		1,939,160
Southwire Company, LLC (f.k.a Southwire Company)	Building and Development	Initial Term Loan	Loan		3.25	%		2/10/2021		497,500		496,388		483,998
SRAM, LLC	Industrial Equipment	Term Loan (First Lien)	Loan		5.25	%		4/10/2020		3,029,045		3,018,608		2,964,678
SS&C Technologies Holdings Europe S.A.R.L.	Business Equipment and Services	2013 Replacement Term B-2 Loan	Loan		3.25	%		6/7/2019		50,646		50,211		50,773
SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.	Business Equipment and Services	2013 Replacement Term B-1 Loan	Loan		3.25	%		6/7/2019		489,581		485,413		490,804
Steak ‘n Shake Operations, Inc.	Food Services	Term Loan	Loan		4.75	%		3/19/2021		995,000		985,894		990,025
STHI Holding	Healthcare	Term Loan	Loan		4.50	%		8/6/2021		1,000,000		1,000,000		996,670
SunGard Data Systems Inc. (Solar Capital Corp.)	Conglomerate	Tranche C Term Loan	Loan		3.90	%		2/28/2017		285,352		282,854		284,639
SunGard Data Systems Inc. (Solar Capital Corp.)	Conglomerate	Tranche E Term Loan	Loan		4.00	%		3/9/2020		3,707,953		3,614,501		3,694,975
SuperMedia Inc. (fka Idearc Inc.)	Publishing	Loan	Loan		11.60	%		12/30/2016		246,572		239,414		199,518
Syniverse Holdings, Inc.	Telecommunications	Initial Term Loan	Loan		4.00	%		4/23/2019		479,913		475,914		470,915
Taminco Global Chemical Corporation	Chemicals/Plastics	Initial Tranche B-3 Dollar Term Loan	Loan		3.25	%		2/15/2019		1,462,809		1,454,095		1,455,948
TGI Friday’s	Food Services	Term Loan B	Loan		5.25	%		7/15/2020		981,136		976,588		979,910
TPF II Power LLC and TPF II Covert Midco LLC	Utilities	Term Loan B	Loan		5.50	%		10/2/2021		500,000		496,450		502,345
TransDigm, Inc.	Aerospace and Defense	Tranche C Term Loan	Loan		3.75	%		2/28/2020		4,859,419		4,869,067		4,814,858
TransFirst	Financial Intermediaries	Term Loan	Loan		5.50	%		11/12/2021		500,000		495,011		501,095
TransUnion	Financial Intermediaries	Term Loan	Loan		4.00	%		4/9/2021		497,500		496,320		492,649
Tricorbraun, Inc. (fka Kranson Industries, Inc.)	Containers/Glass Products	Term Loan	Loan		4.00	%		5/3/2018		1,902,083		1,894,387		1,882,264
Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)	Healthcare	New Tranche B Term Loan	Loan		4.50	%		6/6/2019		488,806		480,655		478,214
Twin River Management Group, Inc.	Lodging & Casinos	Term Loan B	Loan		5.25	%		7/10/2020		997,500		999,865		1,003,734
U.S. Security Associates Holdings, Inc.	Business Equipment and Services	Delayed Draw Loan	Loan		6.00	%		7/28/2017		158,925		157,926		157,932
U.S. Security Associates Holdings, Inc.	Business Equipment and Services	Term B Loan	Loan		6.00	%		7/28/2017		933,452		928,045		927,618
United Surgical Partners International, Inc.	Healthcare	New Tranche B Term Loan	Loan		4.75	%		4/3/2019		2,437,937		2,413,454		2,436,425
Univar Inc.	Chemicals/Plastics	Term B Loan	Loan		5.00	%		6/30/2017		3,854,959		3,854,719		3,810,781
Univision Communications Inc.	Telecommunications	Replacement First-Lien Term Loan	Loan		4.00	%		3/1/2020		2,955,169		2,938,967		2,924,701
Valeant Pharmaceuticals International, Inc.	Drugs	Series D2 Term Loan B	Loan		3.75	%		2/13/2019		2,545,588		2,537,039		2,528,813
Verint Systems Inc.	Business Equipment and Services	Term Loan	Loan		3.50	%		9/6/2019		1,264,058		1,259,400		1,261,530
Vertafore, Inc.	Business Equipment and Services	Term Loan (2013)	Loan		4.25	%		10/3/2019		2,881,003		2,881,003		2,869,594
Vouvray US Finance	Industrial Equipment	Term Loan	Loan		5.00	%		6/28/2021		498,750		496,358		495,947
Washington Inventory Service	Business Equipment and Services	U.S. Term Loan (First Lien)	Loan		6.75	%		12/20/2018		1,832,876		1,853,317		1,803,092
Wendy’s International, Inc	Food Services	Term B Loan	Loan		3.25	%		5/15/2019		675,340		669,494		670,768
West Corporation	Telecommunications	Term B-10 Loan	Loan		3.25	%		6/30/2018		2,571,560		2,608,260		2,540,212

											$	300,731,616	$	297,038,596

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2014


Issuer Name	Industry	Asset Name	Asset Type	Current Rate			Maturity Date		Principal		Cost			Fair Value
Academy, LTD.	Retailers (Except Food and Drugs)	Initial Term Loan (2012)	Loan		4.50	%		8/3/2018	$	1,960,187	$	1,948,853		$	1,969,969
Acosta, Inc.	Food Products	Term B Loan (2013)	Loan		4.25	%		3/2/2018		4,162,740		4,101,035			4,177,310
Aderant North America, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		6.25	%		12/20/2018		3,473,750		3,470,186			3,482,434
Aegis Toxicology Sciences Corporation	Healthcare	Initial Term Loan (First Lien)	Loan		5.50	%		2/24/2021		1,000,000		990,000			990,000
Aegis Toxicology Sciences Corporation	Healthcare	Initial Term Loan (Second Lien)	Loan		9.50	%		8/24/2021		500,000		492,500			492,500
Aeroflex Incorporated	Aerospace and Defense	Tranche B-1 Term Loan	Loan		4.50	%		11/9/2019		3,208,854		3,194,690			3,223,550
Akorn, Inc.	Healthcare	Term Loan B	Loan		4.50	%		11/13/2020		500,000		497,500			503,125
Alere Inc. (fka IM US Holdings, LLC)	Healthcare	Incremental B-1 Term Loan	Loan		4.25	%		6/30/2017		1,960,000		1,930,566			1,968,173
Applied Systems, Inc.	Business Equipment and Services	Term Loan	Loan		4.25	%		12/8/2016		500,000		498,750			498,750
Aramark Corporation	Food Products	LC-2 Facility	Loan		3.69	%		7/26/2016		79,187		79,187			79,206
Aramark Corporation	Food Products	LC-3 Facility	Loan		3.69	%		7/26/2016		43,961		43,961			43,971
Aramark Corporation	Food Products	U.S. Term C Loan	Loan		3.25	%		7/26/2016		3,206,537		3,206,537			3,207,307
Ardagh Holdings USA Inc. (Ardagh Packaging Finance S.A.)	Containers/Glass Products	Dollar Term Loan	Loan		4.25	%		12/17/2019		1,000,000		995,109			1,002,500
ARG IH Corporation	Food Services	Term Loan	Loan		5.00	%		11/15/2020		500,000		498,797			502,500
Asurion, LLC (fka Asurion Corporation)	Insurance	Incremental Tranche B-1 Term Loan	Loan		4.50	%		5/24/2019		5,508,783		5,462,695			5,516,660
Auction.Com, LLC	Business Equipment and Services	Term Loan A-4	Loan		4.66	%		2/28/2017		980,651		979,812			970,845
Autotrader.com, Inc.	Automotive	Tranche B-1 Term Loan	Loan		4.00	%		12/15/2016		3,791,778		3,791,778			3,805,997
Avantor Performance Materials Holdings, Inc.	Chemicals/Plastics	Term Loan	Loan		5.25	%		6/24/2017		4,875,000		4,861,403			4,875,000
AZ Chem US Inc.	Chemicals/Plastics	Term Loan	Loan		5.25	%		12/22/2017		1,355,941		1,329,859			1,362,720
Bass Pro Group, LLC	Retailers (Except Food and Drugs)	New Term Loan	Loan		3.75	%		11/20/2019		498,725		498,126			500,715
Berry Plastics Corporation	Chemicals/Plastics	Term E Loan	Loan		3.75	%		1/6/2021		1,500,000		1,496,250			1,495,500
Big Heart Pet Brands (fka Del Monte Corporation)	Food/Drug Retailers	Initial Term Loan	Loan		3.50	%		3/9/2020		3,000,000		3,022,866			2,999,250
Biomet, Inc.	Healthcare	Dollar Term B-2 Loan	Loan		3.65	%		7/25/2017		1,970,137		1,970,137			1,972,797
BJ’s Wholesale Club, Inc.	Food/Drug Retailers	New 2013 (November) Replacement Loan (First Lien)	Loan		4.50	%		9/26/2019		500,000		497,592			502,750
Bombardier Recreational Products Inc.	Leisure Goods/Activities/Movies	Term B Loan	Loan		4.00	%		1/30/2019		754,286		748,080			756,647
Brickman Group Ltd. LLC, The	Brokers/Dealers/Investment Houses	Initial Term Loan (First Lien)	Loan		4.00	%		12/18/2020		250,000		248,750			250,937
Brock Holdings III, Inc.	Industrial Equipment	Term Loan (First Lien)	Loan		6.75	%		3/16/2017		1,959,839		1,976,826			1,967,188
Burlington Coat Factory Warehouse Corporation	Retailers (Except Food and Drugs)	Term B-2 Loan	Loan		4.25	%		2/23/2017		2,660,377		2,653,889			2,675,675
C.H.I. Overhead Doors, Inc.	Building and Development	Term Loan (First Lien)	Loan		5.50	%		3/18/2019		2,739,013		2,692,934			2,745,861
Camp International Holding Company	Aerospace and Defense	2013 Replacement Term Loan (First Lien)	Loan		4.75	%		5/31/2019		990,000		990,000			999,900
Capital Automotive L.P.	Conglomerate	Tranche B-1 Term Loan Facility	Loan		4.00	%		4/10/2019		2,137,369		2,141,920			2,142,712
Capstone Logistics, LLC	Business Equipment and Services	Term Note A	Loan		6.50	%		9/16/2016		2,658,626		2,637,550			2,618,899
Capsugel Holdings US, Inc.	Drugs	Initial Term Loan	Loan		3.50	%		8/1/2018		3,145,521		3,138,959			3,141,589
Celanese US Holdings LLC	Chemicals/Plastics	Dollar Term C-2 Commitment	Loan		2.25	%		10/31/2016		2,176,323		2,201,894			2,192,254
Charter Communications Operating, LLC	Cable and Satellite Television	Term F Loan	Loan		3.00	%		12/31/2020		2,682,707		2,672,727			2,666,369
CHS/Community Health Systems, Inc.	Healthcare	2017 Term E Loan	Loan		3.48	%		1/25/2017		1,108,908		1,082,718			1,113,987
CHS/Community Health Systems, Inc.	Healthcare	2021 Term D Loan	Loan		4.25	%		1/27/2017		2,955,608		2,862,024			2,980,228
Cinedigm Digital Funding I, LLC	Business Equipment and Services	Term Loan	Loan		3.75	%		2/28/2018		825,121		820,892			825,121
Covanta Energy Corporation	Ecological Services and Equipment	Term Loan	Loan		3.50	%		3/28/2019		491,250		489,468			492,788
CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)	Electronics/Electric	Term B Loan	Loan		5.00	%		2/13/2017		4,622,500		4,611,092			4,622,500
Crosby US Acquisition Corp.	Industrial Equipment	Initial Term Loan (First Lien)	Loan		4.00	%		11/23/2020		750,000		749,094			748,312
Crown Castle Operating Company	Telecommunications/Cellular	Extended Incremental Tranche B-2 Term Loan	Loan		3.25	%		1/31/2019		2,460,196		2,441,025			2,460,316
Culligan International Company	Conglomerate	Dollar Loan (First Lien)	Loan		6.25	%		12/19/2017		787,658		738,102			734,491
Culligan International Company	Conglomerate	Dollar Loan (Second Lien)	Loan		9.50	%		6/19/2018		783,162		732,061			657,856
Cumulus Media Holdings Inc.	Broadcast Radio and Television	Term Loan	Loan		4.25	%		12/23/2020		500,000		495,000			502,815
DaVita HealthCare Partners Inc. (fka DaVita Inc.)	Healthcare	Tranche B Term Loan	Loan		4.50	%		10/20/2016		3,909,320		3,909,320			3,927,655
DCS Business Services, Inc.	Financial Intermediaries	Term B Loan	Loan		7.25	%		3/19/2018		3,831,595		3,792,824			3,735,805
DealerTrack Technologies, Inc.	Computers & Electronics	Term Loan	Loan		3.50	%		2/28/2021		500,000		498,750			498,750
Dell International LLC	Retailers (Except Food and Drugs)	Term B Loan	Loan		4.50	%		4/29/2020		1,995,000		1,982,818			1,988,935
Delos Finance	Leasing	Loan	Loan		3.50	%		2/26/2021		500,000		497,500			497,500
Deluxe Entertainment Services Group Inc.	Media	Initial Term Loan	Loan		6.50	%		2/28/2020		1,000,000		1,000,000			1,000,000
Digitalglobe, Inc.	Ecological Services and Equipment	Term Loan	Loan		3.75	%		1/31/2020		248,125		248,125			247,815
Drew Marine Group Inc.	Chemicals/Plastics	Term Loan (First Lien)	Loan		4.50	%		11/19/2020		500,000		499,397			502,500
Dunkin’ Brands, Inc.	Food Services	Term B-4 Loan	Loan		3.25	%		2/14/2020		3,956,731		3,946,925			3,936,948
DynCorp International Inc.	Aerospace and Defense	Term Loan	Loan		6.25	%		7/7/2016		486,442		482,619			488,573
Education Management LLC	Leisure Goods/Activities/Movies	Tranche C-2 Term Loan	Loan		4.31	%		6/1/2016		3,882,152		3,746,734			3,544,405
EIG Investors Corp.	Business Equipment and Services	Term Loan	Loan		5.00	%		11/9/2019		997,500		992,713			1,003,734
Energy Transfer Equity, L.P.	Oil & Gas	Loan	Loan		3.25	%		12/2/2019		1,000,000		997,599			998,750
Evergreen Acqco 1 LP	Retailers (Except Food and Drugs)	New Term Loan	Loan		5.00	%		7/9/2019		492,516		488,615			493,900
EWT Holdings III Corp. (fka WTG Holdings III Corp.)	Industrial Equipment	Term Loan (First Lien)	Loan		4.75	%		1/15/2021		1,000,000		995,084			1,002,500
Federal-Mogul Corporation	Automotive	Tranche B Term Loan	Loan		2.14	%		12/29/2014		2,220,981		2,187,068			2,202,747
Federal-Mogul Corporation	Automotive	Tranche C Term Loan	Loan		2.14	%		12/28/2015		1,307,032		1,270,847			1,296,301
First Data Corporation	Financial Intermediaries	2017 Second New Dollar Term Loan	Loan		4.20	%		3/24/2017		2,111,028		2,010,799			2,109,276
First Data Corporation	Financial Intermediaries	2018 Dollar Term Loan	Loan		4.20	%		3/23/2018		2,290,451		2,231,370			2,292,741
FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)	Nonferrous Metals/Minerals	Loan	Loan		4.25	%		6/28/2019		997,500		995,122			1,006,438
Four Seasons Holdings Inc.	Lodging & Casinos	Term Loan (First Lien)	Loan		3.50	%		6/27/2020		498,750		498,750			498,750
Garda World Security Corporation	Business Equipment and Services	Term B Delayed Draw Loan	Loan		4.00	%		11/6/2020		203,194		202,218			203,363
Garda World Security Corporation	Business Equipment and Services	Term B Loan	Loan		4.00	%		11/6/2020		794,306		790,489			794,965
Gardner Denver, Inc.	Oil & Gas	Initial Dollar Term Loan	Loan		4.25	%		7/30/2020		1,496,250		1,485,394			1,489,337
Generac Power Systems, Inc.	Industrial Equipment	Term Loan B	Loan		3.50	%		5/31/2020		868,414		852,908			868,258
General Nutrition Centers, Inc.	Retailers (Except Food and Drugs)	Amended Tranche B Term Loan	Loan		3.25	%		3/4/2019		4,740,112		4,722,664			4,725,892
Global Tel*Link Corporation	Business Equipment and Services	Term Loan (First Lien)	Loan		5.00	%		5/23/2020		1,920,175		1,915,905			1,900,014
Goodyear Tire & Rubber Company, The	Chemicals/Plastics	Loan (Second Lien)	Loan		4.75	%		4/30/2019		4,000,000		3,941,039			4,037,000
Grosvenor Capital Management Holdings, LP	Brokers/Dealers/Investment Houses	Initial Term Loan	Loan		3.75	%		1/4/2021		3,500,000		3,482,803			3,489,080
Harland Clarke Holdings Corp. (fka Clarke American Corp.)	Publishing	Tranche B-4 Term Loan	Loan		6.00	%		8/4/2019		500,000		497,500			500,780
HCA Inc.	Healthcare	Tranche B-4 Term Loan	Loan		2.94	%		5/1/2018		5,720,353		5,390,148			5,713,947
Hertz Corporation, The	Automotive	Tranche B-1 Term Loan	Loan		3.75	%		3/11/2018		2,970,000		3,005,791			2,973,683
Hologic, Inc.	Healthcare	Refinancing Tranche A Term Loan	Loan		2.19	%		8/1/2017		2,312,500		2,307,973			2,313,425
Hunter Defense Technologies, Inc.	Aerospace and Defense	Term Loan	Loan		3.45	%		8/22/2014		3,470,285		3,460,723			3,262,068
Huntsman International LLC	Chemicals/Plastics	Extended Term B Loan	Loan		2.73	%		4/19/2017		3,920,000		3,892,467			3,919,020
Ikaria, Inc.	Healthcare	Initial Term Loan (First Lien)	Loan		5.00	%		2/12/2021		500,000		497,515			502,815
Infor (US), Inc. (fka Lawson Software Inc.)	Business Equipment and Services	Tranche B-5 Term Loan	Loan		3.75	%		6/3/2020		1,776,183		1,758,861			1,772,488
Inventiv Health, Inc. (fka Ventive Health, Inc)	Conglomerate	Consolidated Term Loan	Loan		7.50	%		8/4/2016		492,090		492,090			491,105
J. Crew Group, Inc.	Retailers (Except Food and Drugs)	Term B-1 Loan Retired 03/05/2014	Loan		4.00	%		3/7/2018		972,500		972,500			972,656
JFB Firth Rixson Inc.	Industrial Equipment	2013 Replacement Dollar Term Facility Loan	Loan		4.25	%		6/30/2017		2,564,311		2,554,534			2,568,054
Kinetic Concepts, Inc.	Healthcare	Dollar Term D-1 Loan	Loan		4.00	%		5/4/2018		490,057		475,404			492,508
La Quinta Intermediate Holdings L.L.C	Gaming and Hotels	Initial Term Loan	Loan		4.00	%		2/19/2021		500,000		500,000			500,000
Michaels Stores, Inc.	Retailers (Except Food and Drugs)	Term B Loan	Loan		3.75	%		1/28/2020		496,250		496,250			497,302
Microsemi Corporation	Electronics/Electric	Incremental Term Loan	Loan		3.75	%		2/19/2020		498,750		498,750			499,373
Microsemi Corporation	Electronics/Electric	Term Loan	Loan		3.50	%		2/19/2020		2,393,981		2,389,463			2,398,482
Mitel US Holdings, Inc.	Telecommunications	Term Loan	Loan		5.25	%		1/31/2020		250,000		248,753			252,083
National CineMedia, LLC	Leisure Goods/Activities/Movies	Term Loan (2013)	Loan		2.95	%		11/26/2019		1,086,207		1,054,177			1,082,134
Newsday, LLC	Publishing	Term Loan	Loan		3.69	%		10/12/2016		2,215,385		2,213,416			2,215,385
Novelis, Inc.	Conglomerate	Initial Term Loan	Loan		3.75	%		3/10/2017		4,857,520		4,868,347			4,873,452
NPC International, Inc.	Food Services	Term Loan (2013)	Loan		4.00	%		12/28/2018		490,833		490,833			493,597
NRG Energy, Inc.	Utilities	Term Loan (2013)	Loan		2.75	%		7/1/2018		3,900,525		3,875,534			3,872,168
NuSil Technology LLC.	Chemicals/Plastics	Term Loan	Loan		5.25	%		4/7/2017		809,163		809,163			799,558
OEP Pearl Dutch Acquisition B.V.	Chemicals/Plastics	Initial BV Term Loan	Loan		6.50	%		3/30/2018		142,422		140,466			143,846
On Assignment, Inc.	Business Equipment and Services	Initial Term B Loan	Loan		3.50	%		5/15/2020		1,311,364		1,303,125			1,312,190
Onex Carestream Finance LP	Healthcare	Term Loan (First Lien 2013)	Loan		5.00	%		2/25/2017		4,531,159		4,511,264			4,582,135
OpenLink International, Inc.	Computers & Electronics	Replacement Term Loan	Loan		6.25	%		10/30/2017		980,000		980,000			980,000
P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)	Food/Drug Retailers	Term Borrowing	Loan		5.50	%		6/22/2019		1,496,212		1,488,641			1,509,675
P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)	Business Equipment and Services	Term Loan (First Lien)	Loan		5.00	%		10/30/2020		1,000,000		995,186			1,008,750
Patheon Inc.	Healthcare	Term Loan	Loan		4.25	%		3/11/2021		3,000,000		2,992,500			2,990,640
PetCo Animal Supplies, Inc.	Retailers (Except Food and Drugs)	New Loans	Loan		4.00	%		11/24/2017		1,484,694		1,483,250			1,489,103
Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)	Conglomerate	2013 Term Loan	Loan		4.00	%		12/5/2018		1,960,200		1,936,226			1,967,845
Pinnacle Foods Finance LLC	Food Products	New Term Loan G	Loan		3.25	%		4/29/2020		4,962,500		4,951,514			4,942,352
Polymer Group, Inc.	Chemicals/Plastics	Initial Loan	Loan		5.25	%		12/19/2019		500,000		497,500			501,875
Prestige Brands, Inc.	Drugs	Term B-1 Loan	Loan		3.75	%		1/31/2019		435,606		430,195			437,022
Pro Mach, Inc.	Industrial Equipment	Term Loan	Loan		4.50	%		7/6/2017		1,945,655		1,934,699			1,955,383
Progressive Waste Solutions Ltd.	Ecological Services and Equipment	Term B Loan	Loan		3.00	%		10/24/2019		498,741		498,741			500,486
Quintiles Transnational Corp.	Conglomerate	Term B-3 Loan	Loan		3.75	%		6/8/2018		3,681,541		3,646,328			3,685,186
Redtop Acquisitions Limited	Electronics/Electric	Initial Dollar Term Loan (First Lien)	Loan		4.50	%		12/3/2020		500,000		496,369			502,915
Rexnord LLC/RBS Global, Inc.	Industrial Equipment	Term B Loan	Loan		4.00	%		4/1/2018		1,663,476		1,663,476			1,667,035
Reynolds Group Holdings Inc.	Industrial Equipment	Incremental U.S. Term Loan	Loan		4.00	%		9/28/2018		1,980,000		1,980,000			1,993,365
Rocket Software, Inc.	Business Equipment and Services	Term Loan (First Lien)	Loan		5.75	%		2/8/2018		1,960,025		1,934,083			1,960,515
Rovi Solutions Corporation / Rovi Guides, Inc.	Electronics/Electric	Tranche A-2 Loan	Loan		2.45	%		3/29/2017		1,562,552		1,552,098			1,562,552
Rovi Solutions Corporation / Rovi Guides, Inc.	Electronics/Electric	Tranche B-3 Term Loan	Loan		3.50	%		3/29/2019		1,344,450		1,339,560			1,341,088
RPI Finance Trust	Drugs	Term B-2 Term Loan	Loan		3.25	%		5/9/2018		5,308,218		5,283,397			5,339,165
Scitor Corporation	Business Equipment and Services	Term Loan	Loan		5.00	%		2/15/2017		463,977		462,831			460,354
Sensata Technologies B.V./Sensata Technology Finance Company, LLC	Industrial Equipment	Term Loan	Loan		3.25	%		5/12/2019		1,524,730		1,524,730			1,529,106
Sensus USA Inc. (fka Sensus Metering Systems)	Utilities	Term Loan (First Lien)	Loan		5.75	%		5/9/2017		1,945,013		1,939,821			1,957,987
ServiceMaster Company, The	Conglomerate	Tranche B Term Loan	Loan		4.45	%		1/31/2017		2,822,729		2,830,165			2,825,552
SI Organization, Inc., The	Aerospace and Defense	New Tranche B Term Loan	Loan		5.50	%		11/22/2016		3,880,675		3,863,008			3,800,655
Sonneborn, LLC	Chemicals/Plastics	Initial US Term Loan	Loan		6.50	%		3/30/2018		807,059		795,976			815,130
Sophia, L.P.	Electronics/Electric	Term B Loan	Loan		4.50	%		7/19/2018		928,389		917,174			934,191
Southwire Company, LLC (f.k.a Southwire Company)	Building and Development	Initial Term Loan	Loan		3.25	%		2/10/2021		500,000		498,758			499,730
SRA International Inc.	Aerospace and Defense	Term Loan	Loan		6.50	%		7/20/2018		3,268,571		3,184,532			3,276,743
SRAM, LLC	Industrial Equipment	Term Loan (First Lien)	Loan		4.01	%		4/10/2020		3,304,614		3,278,551			3,304,614
SS&C Technologies Holdings Europe S.A.R.L.	Business Equipment and Services	2013 Replacement Term B-2 Loan	Loan		3.25	%		6/7/2019		64,638		64,070			64,839
SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.	Business Equipment and Services	2013 Replacement Term B-1 Loan	Loan		3.25	%		6/7/2019		624,838		619,344			626,782
SunCoke Energy, Inc.	Nonferrous Metals/Minerals	Tranche B Term Loan	Loan		4.00	%		7/26/2018		1,367,311		1,359,200			1,367,311
SunGard Data Systems Inc (Solar Capital Corp.)	Conglomerate	Tranche C Term Loan	Loan		3.95	%		2/28/2017		304,311		302,167			305,452
SunGard Data Systems Inc (Solar Capital Corp.)	Conglomerate	Tranche E Term Loan	Loan		4.00	%		3/8/2020		4,221,845		4,096,936			4,238,944
SuperMedia Inc. (fka Idearc Inc.)	Publishing	Loan	Loan		11.60	%		12/30/2016		264,330		257,131			196,762
Syniverse Holdings, Inc.	Telecommunications	Initial Term Loan	Loan		4.00	%		4/23/2019		479,913		476,371			480,911
Taminco Global Chemical Corporation	Chemicals/Plastics	Initial Tranche B-3 Dollar Term Loan	Loan		3.25	%		2/15/2019		1,473,863		1,464,165			1,473,406
Team Health, Inc.	Healthcare	Tranche B Term Loan	Loan		3.75	%		6/29/2018		4,387,500		4,373,856			4,387,500
TECTUM HOLDINGS INC	Industrial Equipment	Term Loan	Loan		6.50	%		12/3/2015		3,800,160		3,788,706			3,762,159
Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)	Conglomerate	Term B-2 Loan	Loan		3.75	%		9/29/2016		2,356,680		2,360,795			2,361,982
TransDigm Inc.	Aerospace and Defense	Tranche C Term Loan	Loan		3.75	%		2/28/2020		4,896,514		4,904,843			4,914,876
Tricorbraun Inc. (fka Kranson Industries, Inc.)	Containers/Glass Products	Term Loan	Loan		4.00	%		5/3/2018		1,902,083		1,895,432			1,903,282
Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)	Healthcare	New Tranche B Term Loan	Loan		4.50	%		6/6/2019		492,528		484,755			493,513
U.S. Security Associates Holdings, Inc.	Business Equipment and Services	Delayed Draw Loan	Loan		6.00	%		7/28/2017		160,148		159,235			160,348
U.S. Security Associates Holdings, Inc.	Business Equipment and Services	Term B Loan	Loan		6.00	%		7/28/2017		122,494		122,109			122,648
U.S. Security Associates Holdings, Inc.	Business Equipment and Services	Term B Loan	Loan		6.00	%		7/28/2017		818,172		813,513			819,195
U.S. Silica Company	Nonferrous Metals/Minerals	Term Loan	Loan		4.00	%		7/23/2020		1,950,200		1,941,292			1,954,256
U.S. Xpress Enterprises, Inc.	Industrial Equipment	Extended Term Loan	Loan		9.38	%		11/13/2016		2,805,278		2,766,405			2,777,225
United Surgical Partners International, Inc.	Healthcare	New Tranche B Term Loan	Loan		4.75	%		4/3/2019		2,456,500		2,429,626			2,470,821
Univar Inc.	Chemicals/Plastics	Term B Loan	Loan		5.00	%		6/30/2017		3,884,944		3,884,238			3,859,225
Univision Communications Inc.	Telecommunications	Replacement First-Lien Term Loan	Loan		4.00	%		3/1/2020		2,977,500		2,959,200			2,984,467
UPC Financing Partnership	Broadcast Radio and Television	Facility AF	Loan		4.00	%		1/31/2021		1,000,000		974,618			1,002,500
Valeant Pharmaceuticals International, Inc.	Drugs	Series D2 Term Loan B	Loan		3.75	%		2/13/2019		2,947,688		2,936,432			2,955,528
Verint Systems Inc.	Business Equipment and Services	Term Loan	Loan		4.00	%		9/6/2019		1,900,800		1,892,737			1,904,602
Verint Systems Inc.	Business Equipment and Services	Tranche B Incremental Term Loan	Loan		3.50	%		9/6/2019		1,000,000		997,521			1,000,000
Vertafore, Inc.	Business Equipment and Services	Term Loan (2013)	Loan		4.25	%		10/3/2019		2,899,621		2,899,621			2,909,770
Visant Corporation (fka Jostens)	Leisure Goods/Activities/Movies	Tranche B Term Loan (2011)	Loan		5.25	%		12/22/2016		3,658,446		3,658,446			3,607,008
W.R. Grace & Co.-CONN	Chemicals/Plastics	Delayed Draw Term Loan	Loan		0.00	%		2/3/2021		—		(328	)		—
W.R. Grace & Co.-CONN	Chemicals/Plastics	U.S. Term Loan	Loan		3.00	%		2/3/2021		368,421		367,502			367,828
Washington Inventory Service	Business Equipment and Services	U.S. Term Loan (First Lien)	Loan		6.75	%		12/20/2018		1,980,000		2,004,187			1,965,150
Wendy’s International, Inc	Food Services	Term B Loan	Loan		3.25	%		5/15/2019		680,469		674,563			679,197
Wesco Aircraft Hardware Corp.	Aerospace and Defense	Tranche B Term Loan	Loan		4.75	%		2/28/2021		500,000		498,750			498,750
West Corporation	Telecommunications	Term B-10 Loan	Loan		3.25	%		6/30/2018		2,926,111		2,976,179			2,909,666

											$	299,137,566		$	300,491,077

Note 5. Agreements and Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 10, 2014, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended November 30, 2014 and 2013, we incurred $1.1 million and $0.9 million in base management fees, respectively. For the three months ended November 30, 2014 and 2013, we accrued $0.7 million and $0.2 million in incentive fees related to pre-incentive fee net investment income. For the three months ended November 30, 2014, we accrued $0.1 million in incentive fees related to capital gains. For the three months ended November 30, 2013, there was a reduction of $0.8 million in incentive management fees related to capital gains. For the nine months ended November 30, 2014 and 2013, we incurred $3.1 million and $2.4 million in base management fees, respectively. For the nine months ended November 30, 2014 and 2013, we accrued $1.6 million and $1.0 million in incentive fees related to pre-incentive fee net investment income. For the nine months ended November 30, 2014, we accrued $0.4 million in incentive management fees related to capital gains. For the nine months ended November 30, 2013, there was a reduction of $0.8 million in incentive management fees related to capital gains. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2014, the base management fees accrual was $1.1 million, and the incentive fees accrual was $3.5 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2014, the base management fees accrual was $0.9 million and the incentive fees accrual was $3.0 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company is capped at $1.0 million for the initial two year term of the administration agreement. On July 10, 2014, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

For the three months ended November 30, 2014 and 2013, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. For the nine months ended November 30, 2014 and 2013, we recognized $0.8 million and $0.8 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. As of November 30, 2014 and February 28, 2014, $0.3 million and $0.4 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

•

expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

•

extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

•

remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

•

extend the commitment termination date from February 24, 2015 to September 17, 2017;

•

extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

•

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

•

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2014 and February 28, 2014, there was $4.9 million and $0.0 million outstanding under the Credit Facility, respectively, and the Company was in compliance with all of the limitations and requirements of the Credit Facility. The carrying amount of the amount outstanding under the Credit Facility approximates its fair value. $2.7 million of financing costs related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended November 30, 2014 and 2013, we recorded $0.2 million and $0.1 million of interest expense related to the Credit Facility, respectively. For the three months ended November 30, 2014 and 2013, we recorded $0.03 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility, respectively. The interest rates during the three and nine months ended November 30, 2014 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. The interest rates during the three and nine months ended November 30, 2013 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. For the nine months ended November 30, 2014 and 2013, we recorded $0.6 million and $0.8 million of interest expense related to the Credit Facility, respectively. For the nine months ended November 30, 2014 and 2013, we recorded $0.2 million and $0.3 million of amortization of deferred financing costs related to the Credit Facility, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 1.25%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.25%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $37.1 million subject to the Credit Facility cap of $45.0 million at November 30, 2014 For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the November 30, 2014 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2014. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of November 30, 2014, we have funded SBIC LP with $59.3 million of equity capital, and have $79.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of November 30, 2014 and February 28, 2014, there was $79.0 million and $50.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $2.7 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three months ended November 30, 2014 and 2013, the Company recorded $0.6 million and $0.3 million, respectively, of interest expense related to the SBA debentures. For the nine months ended November 30, 2014 and 2013, the Company recorded $1.4 million and $0.9 million, respectively, of interest expense related to the SBA debentures. For the three months ended November 30, 2014 and 2013, the Company recorded $0.1 million and $0.05 million, respectively, of amortization of deferred financing costs related to the SBA debentures. For the nine months ended November 30, 2014 and 2013, the Company recorded $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs related to the SBA debentures. The weighted average interest rate during the nine months ended November 30, 2014 and 2013 on the outstanding borrowings of the SBA debentures was 3.16% and 2.99%, respectively.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of November 30, 2014, the carrying amount and fair value of the Notes was $48.3 million and $49.5 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of November 30, 2014, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the three months ended November 30, 2014 and 2013, we recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.1 million and $0.09 million, respectively, of amortization of deferred financing costs related to the Notes. For the nine months ended November 30, 2014 and 2013, we recorded $2.7 million and $2.0 million, respectively, of interest expense and $0.3 million and $0.2 million, respectively, of amortization of deferred financing costs related to the Notes.

Note 7. Commitments and Contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2014:


			Payment Due by Period
	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years
	($ in thousands)
Long-Term Debt Obligations	$	132,200	$	—	$	—	$	—	$	132,200

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $12.8 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2014 and February 28, 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended November 30, 2014 and 2013, we accrued $0.05 million and $0.04 million for directors’ fees expense, respectively. For the nine months ended November 30, 2014 and 2013, we accrued $0.2 million and $0.1 million for directors’ fees expense, respectively. As of November 30, 2014 and February 28, 2014, $0.04 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of November 30, 2014, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. As of November 30, 2014, the Company had not purchased any shares of common stock pursuant to this repurchase plan.

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and nine months ended November 30, 2014 and 2013 (dollars in thousands except share and per share amounts):


	For the three months ended				For the nine months ended
Basic and diluted	November 30, 2014		November 30, 2013		November 30, 2014		November 30, 2013
Net increase in net assets from operations	$	3,466	$	1,268	$	8,360	$	5,026
Weighted average common shares outstanding		5,379,616		4,851,451		5,379,616		4,770,267
Earnings per common share-basic and diluted	$	0.64	$	0.26	$	1.55	$	1.05

Note 11. Dividend

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

Note 12. Financial Highlights

The following is a schedule of financial highlights for the nine months ended November 30, 2014 and 2013:


	For the nine months ended
	November 30, 2014			November 30, 2013
Per share data:
Net asset value at beginning of period	$	21.36		$	22.98
Net investment income(1)		1.27			1.60
Net realized and unrealized gains and (losses) on investments and derivatives		0.29			(0.55	)

Net increase in net assets from operations		1.56			1.05
Distributions declared from net investment income		(0.18	)		(2.65	)
Other (2)		—			(0.71	)

Net asset value at end of period	$	22.74		$	20.67
Net assets at end of period	$	122,315,757		$	111,206,093
Shares outstanding at end of period		5,379,616			5,379,616
Per share market value at end of period	$	15.18		$	15.64
Total return based on market value(3)		(3.55	)%		7.66	%
Total return based on net asset value(4)		7.35	%		5.40	%
Ratio/Supplemental data:
Ratio of net investment income to average, net assets(5)		7.67	%		9.12	%
Ratio of operating expenses to average net assets(5)		6.27	%		5.97	%
Ratio of incentive management fees to average net assets(5)		2.27	%		0.26	%
Ratio of debt related expenses to average net assets(5)		6.13	%		5.18	%
Ratio of total expenses to average net assets(5)		14.66	%		11.42	%
Portfolio turnover rate(6)		22.59	%		36.80	%

(1)	Net investment income per share is calculated using the weighted average shares outstanding during the period.

(2)	Represents the dilutive effect of issuing common stock below net asset value per share during the period.

(3)

Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.

(4)

Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.

(5)	Ratios are annualized.

(6)	Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 13. Subsequent Events

Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no further subsequent events that occurred during such period that would require disclosure in this

Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the quarter ended November 30, 2014.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2014.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

•

our future operating results;

•

our business prospects and the prospects of our portfolio companies;

•

the impact of investments that we expect to make;

•

our contractual arrangements and relationships with third parties;

•

the dependence of our future success on the general economy and its impact on the industries in which we invest;

•

the ability of our portfolio companies to achieve their objectives;

•

our expected financings and investments;

•

our regulatory structure and tax treatment, including our ability to operate as a business development company, a small business investment company and a regulated investment company;

•

the adequacy of our cash resources and working capital;

•

the timing of cash flows, if any, from the operations of our portfolio companies; and

•

the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors. We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

•

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

•

In addition, all our investments are subject to the following valuation process:

•

The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

•

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

•

organization;

•

calculating our net asset value (including the cost and expenses of any independent valuation firm);

•

expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

•

interest payable on debt, if any, incurred to finance our investments;

•

offerings of our common stock and other securities;

•

investment advisory and management fees;

•

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

•

transfer agent and custodial fees;

•

federal and state registration fees;

•

all costs of registration and listing our common stock on any securities exchange;

•

federal, state and local taxes;

•

independent directors’ fees and expenses;

•

costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

•

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

•

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

•

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

•

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.

The incentive fee had two parts:

•

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

•

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Annual Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

•

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

•

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

•

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

Portfolio and investment activity

Corporate Debt Portfolio Overview


	At November 30, 2014			At February 28, 2014
	($ in millions)
Number of investments(1)		60			59
Number of portfolio companies(1)		36			37
Average investment size(1)	$	3.7		$	3.2
Weighted average maturity(1)		3.8	yrs		4.3	yrs
Number of industries(1)		15			16
Average investment per portfolio company(1)	$	6.2		$	5.0
Non-performing or delinquent investments(1)	$	6.0		$	0.3
Fixed rate debt (% of interest bearing portfolio)(2)	$	86.7(40.8	)%	$	70.6(40.1	)%
Weighted average current coupon(2)		11.3	%		12.5	%
Floating rate debt (% of interest bearing portfolio)(2)	$	125.8(59.2	)%	$	105.4(59.9	)%
Weighted average current spread over LIBOR(2)		8.7	%		7.3	%

(1)	Excludes our investment in the subordinated notes of Saratoga CLO.

(2)	Excludes our investment in the subordinated notes of Saratoga CLO and investments in common stocks.

During the three months ended November 30, 2014, we made $30.6 million investments in new or existing portfolio companies and had $26.8 million in aggregate amount of exits and repayments resulting in net investments of $3.8 million for the period. During the three months ended November 30, 2013, we made $22.3 million investments in the new or existing portfolio companies and had $9.9 million in aggregate amount of exits and repayments resulting in net investments of $12.4 million for the period.

During the nine months ended November 30, 2014, we made $84.0 million investments in new or existing portfolio companies and had $51.2 million in aggregate amount of exits and repayments resulting in net investments of $32.8 million for the period. During the nine months ended November 30, 2013, we made $110.1 million investments in new or existing portfolio companies and had $65.0 million in aggregate amount of exits and repayments resulting in net investments of $45.1 million for the period.

Our portfolio composition based on fair value at November 30, 2014 and February 28, 2014 was as follows:

Portfolio composition


	At November 30, 2014						At February 28, 2014
	Percentage of Total Portfolio			Weighted Average Current Yield			Percentage of Total Portfolio			Weighted Average Current Yield
Syndicated loans		10.2	%		6.4	%		15.7	%		6.2	%
First lien term loans		50.0			11.3			39.0			10.7
Second lien term loans		15.2			11.3			13.5			11.1
Senior secured notes		10.3			8.8			14.6			13.8
Unsecured notes		2.5			14.2			2.7			15.2
Saratoga CLO subordinated notes		8.0			27.6			9.5			18.6
Equity interests		3.8			N/A			5.0			N/A

Total		100.0	%		11.9	%		100.0	%		11.8	%

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at November 30, 2014 and February 28, 2014, was composed of $302.6 million and $301.3 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 Ltd. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2014.). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2014, $289.3 million or 97.4% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investment was in default. At February 28, 2014, $298.9 million or 99.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and no Saratoga CLO portfolio investments were in default.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

The CMR distribution of our investments at November 30, 2014 and February 28, 2014 was as follows:

Portfolio CMR distribution


	At November 30, 2014					At February 28, 2014
Color Score	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Green	$	196,496		81.5	%	$	159,207		77.4	%
Yellow		8,339		3.4			8,466		4.1
Red		7,680		3.2			8,270		4.0
N/A(1)		28,658		11.9			29,902		14.5

Total	$	241,173		100.0	%	$	205,845		100.0	%

(1)	Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The CMR distribution of Saratoga CLO investments at November 30, 2014 and February 28, 2014 was as follows:

Portfolio CMR distribution


	At November 30, 2014					At February 28, 2014
Color Score	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Green	$	281,295		94.7	%	$	284,796		94.8	%
Yellow		7,982		2.7			14,106		4.7
Red		7,762		2.6			1,589		0.5

Total	$	297,039		100.0	%	$	300,491		100.0	%

Portfolio composition by industry grouping at fair value

The following table shows the portfolio composition by industry grouping at fair value at November 30, 2014 and February 28, 2014:


	At November 30, 2014					At February 28, 2014
	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Software	$	49,033		20.3	%	$	21,738		10.5	%
Business Services		45,596		18.9			57,330		27.9
Healthcare Services		34,431		14.3			23,810		11.6
Consumer Services		27,862		11.6			21,897		10.6
Structured Finance Securities(1)		19,433		8.1			19,570		9.5
Automotive Aftermarket		10,717		4.4			10,621		5.2
Food and Beverage		10,369		4.3			17,286		8.4
Media		9,844		4.1			—		—
Electronics		6,471		2.7			6,741		3.3
Utilities		6,105		2.5			—		—
Metals		6,020		2.5			6,645		3.2
Manufacturing		5,925		2.5			5,970		2.9
Consumer Products		5,312		2.2			6,118		3.0
Building Products		2,395		1.0			901		0.4
Publishing		1,559		0.6			1,191		0.6
Education		101		0.0			90		0.0
Environmental		—		—			5,249		2.5
Homebuilding		—		—			344		0.2
Aerospace		—		—			344		0.2

Total	$	241,173		100.0	%	$	205,845		100.0	%

(1)	Comprised of our investment in the subordinated notes of Saratoga CLO.

The following table shows the portfolio composition by industry grouping of Saratoga CLO at fair value at November 30, 2014 and February 28, 2014:


	At November 30, 2014					At February 28, 2014
	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Business Equipment and Services	$	37,967		12.8	%	$	28,386		9.4	%
Healthcare		37,054		12.5			37,896		12.6
Chemicals/Plastics		27,244		9.2			26,345		8.8
Retailers (Except Food and Drugs)		20,008		6.7			15,314		5.1
Conglomerate		19,939		6.7			24,285		8.1
Industrial Equipment		15,374		5.2			24,143		8.0
Electronics/Electric		12,863		4.3			11,861		4.0
Leisure Goods/Activities/Movies		12,726		4.2			8,990		3.0
Financial Intermediaries		10,753		3.6			8,138		2.7
Drugs		10,115		3.4			11,873		4.0
Food Services		8,472		2.9			5,612		1.9
Aerospace and Defense		7,281		2.5			20,465		6.8
Oil and Gas		6,872		2.3			2,488		0.8
Telecommunications		6,651		2.2			6,627		2.2
Automotive		6,640		2.2			10,279		3.4
Containers/Glass Products		6,353		2.1			2,906		1.0
Utilities		6,212		2.1			5,830		1.9
Lodging and Casinos		5,847		2.0			499		0.2
Food Products		5,809		2.0			12,450		4.1
Food/Drug Retailers		5,773		1.9			5,012		1.7
Publishing		5,628		1.9			2,913		1.0
Insurance		5,427		1.8			5,517		1.8
Brokers/Dealers/Investment Houses		4,881		1.6			3,740		1.2
Cable and Satellite Television		2,624		0.9			2,666		0.9
Telecommunications/Cellular		2,431		0.8			2,460		0.8
Media		2,005		0.7			1,000		0.3
Nonferrous Metals/Minerals		1,849		0.6			4,328		1.4
Ecological Services and Equipment		826		0.3			1,241		0.4
Building and Development		484		0.2			3,246		1.1
Broadcast Radio and Television		475		0.2			1,505		0.5
Health Insurance		456		0.2			—		—
Computers and Electronics		—		—			1,479		0.5
Gaming and Hotels		—		—			500		0.2
Leasing		—		—			497		0.2

Total	$	297,039		100.0	%	$	300,491		100.0	%

Portfolio composition by geographic location at fair value

The following table shows the portfolio composition by geographic location at fair value at November 30, 2014 and February 28, 2014. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.


	At November 30, 2014					At February 28, 2014
	Investments at Fair Value		Percentage of Total Portfolio			Investments at Fair Value		Percentage of Total Portfolio
	($ in thousands)
Southeast	$	95,893		39.8	%	$	83,161		40.4	%
Midwest		43,031		17.8			41,453		20.1
Northeast		42,779		17.7			17,191		8.4
West		40,037		16.6			44,470		21.6
Other(1)		19,433		8.1			19,570		9.5

Total	$	241,173		100.0	%	$	205,845		100.0	%

(1)	Comprised of our investment in the subordinated notes of Saratoga CLO.

Results of operations

Operating results for the three and nine months ended November 30, 2014 and 2013 are as follows:


	For the three months ended
	November 30, 2014			November 30, 2013
	($ in thousands)
Total investment income	$	7,305		$	5,801
Total expenses, net		4,595			2,903

Net investment income		2,710			2,898
Net realized gains		2,761			83
Net unrealized losses		(2,005	)		(1,713	)

Net increase in net assets resulting from operations	$	3,466		$	1,268


	For the nine months ended
	November 30, 2014			November 30, 2013
	($ in thousands)
Total investment income	$	19,924		$	17,206
Total expenses, net		13,081			9,567

Net investment income		6,843			7,639
Net realized gains		3,203			1,158
Net unrealized losses		(1,686	)		(3,771	)

Net increase in net assets resulting from operations	$	8,360		$	5,026

Investment income

The composition of our investment income for the three and nine months ended November 30, 2014 and 2013 was as follows:


	For the three months ended
	November 30, 2014		November 30, 2013
	($ in thousands)
Interest from investments	$	6,054	$	4,997
Management fee income from Saratoga CLO		383		421
Interest from cash and cash equivalents and other income		868		383

Total investment income	$	7,305	$	5,801


	For the nine months ended
	November 30, 2014		November 30, 2013
	($ in thousands)
Interest from investments	$	17,693	$	14,961
Management fee income from Saratoga CLO		1,150		1,400
Interest from cash and cash equivalents and other income		1,081		845

Total investment income	$	19,924	$	17,206

For the three months ended November 30, 2014, total investment income increased $1.5 million, or 25.9% compared to the three months ended November 30, 2013. Interest income from investments increased $1.1 million, or 21.2%, to $6.1 million for the three months ended November 30, 2014, from $5.0 million for the three months ended November 30, 2013. This reflects an increase of 21.3% in total investments to $241.2 million at November 30, 2014 from $198.8 million at November 30, 2013, with the weighted average yield also increasing to 11.9% from 10.8%. In addition, other income increased $0.5 million, or 127.4% from $0.4 million for the three months ended November 30, 2013 to $0.9 million for the three months ended November 30, 2014, reflecting the receipt of an increased number of dividends during those three months.

For the nine months ended November 30, 2014, total investment income increased $2.7 million, or 15.8%, compared to the nine months ended November 30, 2013. Interest income from investments increased $2.7 million, or 18.3%, to $17.7 million for the nine months ended November 30, 2014, from $15.0 million for the nine months ended November 30, 2013. This reflects an increase of 21.3% in total investments to $241.2 million at November 30, 2014 from $198.8 million at November 30, 2013, with the weighted average yield also increasing to 11.9% from 10.8%.

For the three and nine months ended November 30, 2014 and 2013, total PIK income was $0.3 million and $0.9 million, and $0.2 million and $0.6 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we receive from Saratoga CLO has declined from historical periods decreasing $0.04 million, or 9.0%, to $0.4 million and $0.2 million, or 17.9%, to $1.2 million, respectively, for the three and nine months ended November 30, 2014 from $0.4 million and $1.4 million for the three and nine months ended November 30, 2013, respectively.

Operating expenses

The composition of our expenses for the three and nine months ended November 30, 2014 and 2013 was as follows:

Operating Expenses


	For the three months ended
	November 30, 2014		November 30, 2013
	($ in thousands)
Interest and debt financing expenses	$	1,869	$	1,611
Base management fees		1,088		876
Professional fees		226		313
Incentive management fees		852		(561	)
Administrator expenses		250		250
Insurance		83		118
Directors fees and expenses		51		36
General and administrative and other expenses		176		260

Total expenses	$	4,595	$	2,903


	For the nine months ended
	November 30, 2014		November 30, 2013
	($ in thousands)
Interest and debt financing expenses	$	5,466	$	4,343
Base management fees		3,093		2,424
Professional fees		937		879
Incentive management fees		2,022		220
Administrator expenses		750		750
Insurance		252		357
Directors fees and expenses		160		132
General and administrative and other expenses		401		462

Total expenses	$	13,081	$	9,567

For the three months ended November 30, 2014, total operating expenses increased $1.7 million, or 58.3% compared to the three months ended November 30, 2013. For the nine months ended November 30, 2014, total operating expenses increased $3.5 million or 36.7% compared to the nine months ended November 30, 2013.

For the three months ended November 30, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with higher levels of both the SBA debentures and the revolving credit facility outstanding. For the three months ended November 30, 2014, the weighted average interest rate on our outstanding indebtedness was 4.97% compared to 5.55% for the three months ended November 30, 2013. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate but now make up a higher proportion of our overall debt, increasing from 43.3% of overall debt as of November 30, 2013 to 59.8% as of November 30, 2014.

For the nine months ended November 30, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with increased levels of both the SBA debentures and the revolving credit facility outstanding. For the nine months ended November 30, 2014, the weighted average interest rate on our outstanding indebtedness was 5.13% for both the nine months ended November 30, 2013 and 2014.

For the three months ended November 30, 2014, base management fees increased $0.2 million, or 24.2% compared to the three months ended November 30, 2013. For the nine months ended November 30, 2014, base management fees increased $0.7 million, or 27.6% compared to the nine months ended November 30, 2013. The increase in base management fees results from the increase in the average value of our total assets, less cash and cash equivalents, from $200.9 million to $246.6 million as of November 30, 2013 and 2014, respectively.

For the three and nine months ended November 30, 2014, professional fees decreased $0.1 million or 27.8%, and increased $0.1 million, or 6.6%, respectively, compared to the three and nine months ended November 30, 2013.

For the three months ended November 30, 2014, incentive management fees increased $1.4 million compared to the three months ended November 30, 2013. For the three months ended November 30, 2014 incentive management fees were $0.9 million. For the three months ended November 30, 2013 there was a reduction of $0.5 million in incentive management fees which was related to capital losses, thereby offsetting incentive fees expense related to investment income. For the nine months ended November 30, 2014, incentive management fees increased $1.8 million or 819.1% compared to the nine months ended November 30, 2013. The increase in incentive management fees is primarily attributable to an increase in accrued incentive fees related to higher net investment income and incentive fee capital gains, offset by incentive management fee credits for the three months ended November 30, 2013, driven by net unrealized losses in that period.

As discussed above, the increase in interest and credit facility expense for the three and nine months ended November 30, 2014 and 2013 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the nine months ended November 30, 2014, the weighted average interest rate on the outstanding borrowings under the Credit Facility and notes payable was 7.50%, however the notes were only issued and outstanding from May 10, 2013, while they were outstanding for the full nine months ended November 30, 2014. For the three months ended November 30, 2014 and 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.16% and 3.16%, respectively. For the nine months ended November 30, 2014 and 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.16% and 2.99%, respectively.

Net realized gains/losses on sales of investments

For the three months ended November 30, 2014, the Company had $26.8 million of sales, repayments, exits or restructurings resulting in $2.8 million of net realized gains.

For the nine months ended November 30, 2014, the Company had $51.2 million of sales, repayments, exits or restructurings resulting in $3.2 million of net realized gains.

For the three months ended November 30, 2013, the Company had $9.9 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains.

For the nine months ended November 30, 2013, the Company had $65.0 million of sales, repayments, exits or restructurings resulting in $1.2 million of net realized gains.

Net unrealized appreciation/depreciation on investments

For the three months ended November 30, 2014, our investments had net unrealized depreciation of $2.0 million versus net unrealized depreciation of $1.7 million for the three months ended November 30, 2013. For the nine months ended November 30, 2014, our investments had net unrealized depreciation of $1.7 million versus net unrealized depreciation of $3.8 million for the nine months ended November 30, 2013. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2014, were the following:

Nine Months ended November 30, 2014


Issuer	Asset Type	Cost		Fair Value		Total Unrealized Appreciation/ (Depreciation)			YTD Change in Unrealized Appreciation/ (Depreciation)
				($ in thousands)
Elyria Foundry Company, L.L.C.	Senior Secured Note	$	8,860	$	6,020	$	(2,840	)	$	(624	)
Legacy Cabinets Holdings	Common A-1		221		1,468		1,247			916
Targus Holdings, Inc.	Common		567		—		(567	)		(730	)

The $0.6 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a decline in the company’s performance as a result of volume declines from key energy customers.

The $0.9 million of unrealized appreciation in our investment in Legacy Cabinets, Inc. was driven by significant fundamental growth, which increased the fair market value of the equity.

The $0.7 million of unrealized depreciation in our investment in Targus Holdings, Inc. was due to a decline in earnings resulting from weakened demand in the company’s end markets.

The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2013, were the following:

Nine months ended November 30, 2013


Issuer	Asset Type	Cost		Fair Value		Total Unrealized Appreciation/ (Depreciation)		YTD Change in Unrealized Appreciation/ (Depreciation)
				($ in thousands)
Elyria Foundry Company, L.L.C.	Senior Secured Note	$	8,860	$	6,685	$	2,175	$	(2,174	)
Saratoga CLO	Other/ Structured Finance Securities		16,555		19,019		2,464		(4,109	)
USS Parent Holding Corp.	Voting Common Stock		3,026		4,381		1,355		1,515

The $2.2 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a weakened demand in oil and gas end-markets.

The $4.1 million of unrealized depreciation in our investment in the Saratoga CLO subordinated notes was due to lower net present value of projected future cash flows due to a smaller total portfolio and higher financing costs.

The $1.5 million of unrealized appreciation in our investment in the common stock of USS Parent Holding Corp. was due to improved operating performance.

Changes in net assets resulting from operations

For the three months ended November 30, 2014, we recorded a net increase in net assets resulting from operations of $3.5 million versus a net increase in net assets resulting from operations of $1.3 million for the three months ended November 30, 2013. Based on 5,379,616 and 4,851,451 weighted average common shares outstanding for the three months ended November 30, 2014 and November 30, 2013, respectively, our per share net increase in net assets resulting from operations was $0.64 for the three months ended November 30, 2014 versus a per share net increase in net assets from operations of $0.26 for the three months ended November 30, 2013.

For the nine months ended November 30, 2014, we recorded a net increase in net assets resulting from operations of $8.4 million versus a net increase in net assets resulting from operations of $5.0 million for the nine months ended November 30, 2013. Based on 5,379,616 and 4,770,267 weighted average common shares outstanding for the nine months ended November 30, 2014 and November 30, 2013, respectively, our per share net increase in net assets resulting from operations was $1.55 for the nine months ended November 30, 2014 versus a per share net increase in net assets from operations of $1.05 for the nine months ended November 30, 2013.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 30, 2014 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 30, 2015 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 30, 2015 or our next annual meeting of stockholders.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 329.9% as of November 30, 2014 and 337.9% as of February 28, 2014. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

•

Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

•

Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

•

Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

•

an Interest Coverage Ratio of less than 150.0%;

•

an Overcollateralization Ratio of less than 175.0%;

•

the filing of certain ERISA or tax liens;

•

the occurrence of certain “Manager Events” such as:

•

failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

•

failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

•

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

•

resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

•

occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

•

expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

•

extend the Revolving Period from July 30, 2013 to February 24, 2015; and

•

remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

•

extend the commitment termination date from February 24, 2015 to September 17, 2017;

•

extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

•

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

•

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2014, we had $4.9 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2014, we had no outstanding balance under the Credit Facility and $50.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at November 30, 2014 and February 28, 2014 was $37.1 million, and $44.6 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 329.9% as of November 30, 2014 and 337.9% as of February 28, 2014.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of November 30, 2014, our SBIC subsidiary had $59.3 million in regulatory capital and $79.0 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

•

we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

•

we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

At November 30, 2014 and February 28, 2014, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:


	At November 30, 2014					At February 28, 2014
	Fair Value		Percent of Total			Fair Value		Percent of Total
	($ in thousands)
Cash and cash equivalents	$	809		0.3	%	$	3,294		1.6	%
Cash and cash equivalents, securitization accounts		10,738		4.2			3,293		1.6
Syndicated loans		24,523		9.7			32,390		15.2
First lien term loans		120,627		47.7			80,246		37.8
Second lien term loans		36,601		14.5			27,804		13.1
Senior secured notes		24,791		9.8			30,032		14.1
Unsecured notes		5,973		2.4			5,471		2.6
Structured finance securities		19,433		7.7			19,570		9.2
Equity Interest		9,225		3.7			10,332		4.8

Total	$	252,720		100.0	%	$	212,432		100.0	%

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2014:


			Payment Due by Period
	Total		Less Than 1 Year		1 - 3 Years		3 - 5 Years		More Than 5 Years
	($ in thousands)
Long-Term Debt Obligations	$	132,200	$	—	$	—	$	—	$	132,200

Off-balance sheet arrangements

On July 10, 2014, our board of directors appointed Henri J. Steenkamp to serve as our Chief Financial Officer and Chief Compliance Officer. As previously disclosed, Mr. Steenkamp was previously appointed to serve as our Interim Chief Financial Officer and Interim Chief Compliance Officer on March 4, 2014.

On July 10, 2014, our board of directors, including a majority of the independent directors, approved the annual continuation of our investment advisory and management agreement with Saratoga Investment Advisors, LLC. Our board of directors also approved the renewal of the administration agreement with Saratoga Investment Advisors, LLC for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term.

Recent Developments

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 28, 2014.

Item 4. Controls and Procedures

(a)

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

(b)	There have been no changes in our internal control over financial reporting that occurred during the quarter ended November 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP

(NJ), L.P. The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of the Management Agreement with us, and that the termination of the Management Agreement was itself a fraudulent transfer. These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent. The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion. We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

Except as discussed above, neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

Other than as set forth below, there have been no material changes from the risk factors set forth in our annual report on Form 10-K for the year ended February 28, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):


Exhibit Number		Description of Document

31.1*		Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

31.2*		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

32.1*		Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

32.2*		Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

*	Submitted herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	SARATOGA INVESTMENT CORP.

Date: January 14, 2015	By	/s/ CHRISTIAN L. OBERBECK
		Christian L. Oberbeck
		Chief Executive Officer

	By	/s/ HENRI J. STEENKAMP
		Henri J. Steenkamp
		Chief Financial Officer and Chief Compliance Officer

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Christian L. Oberbeck, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 14, 2015

/s/ CHRISTIAN L. OBERBECK

Christian L. Oberbeck

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Henri J. Steenkamp, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 14, 2015

/s/ HENRI J. STEENKAMP

Name: Henri J. Steenkamp

Chief Financial Officer and Chief Compliance Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The certification set forth below is being submitted in connection with the accompanying Quarterly Report of Saratoga Investment Corp. on Form 10-Q (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Christian L. Oberbeck, the Chief Executive Officer, certifies that, to the best of his knowledge:

1.	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

2.	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

Date: January 14, 2015

/s/ CHRISTIAN L. OBERBECK

Name: Christian L. Oberbeck

Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Henri J. Steenkamp, the Chief Financial Officer, Chief Compliance Officer and Secretary of Saratoga Investment Corp., certifies that, to the best of his knowledge:

1.	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

2.	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

Date: January 14, 2015

/s/ HENRI J. STEENKAMP

Name: Henri J. Steenkamp

Chief Financial Officer and Chief Compliance Officer